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ABSTRACT

Entamoeba histolytica is an intestinal protozoan parasite and is the causative
agent of amoebiasis. Upon entering the human host, cellular processes such as adhesion,
phagocytosis, motility and secretion play a vital role in its propagation and pathogenicity.
In other systems, each of these cellular processes is preceded by activation of signal
transduction pathways, which often involve membrane phosphoinositides such as
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2). Little is known about phosphoinositide
signaling in E. histolytica pathogenicity. In this study, we demonstrated that PI(4,5)P2 is
localized to cholesterol-rich microdomains, lipid rafts, of the E. histolytica membrane and
to the trailing edge of the polarized trophozoites. Since cholesterol correlates with
virulence, we utilized cholesterol as a tool to determine the effect on subcellular and
submembrane localization of PI(4,5)P2. Our data suggest that in E. histolytica, PI(4,5)P2
may signal from lipid rafts and cholesterol may play a role in triggering PI(4,5)P2mediated signaling to enhance the motility of this pathogen.
We also utilized a functional genomics approach to identify genes that may
operate in the phosphatidylinositol 3-kinase (PI3K) pathway in E. histolytica. Genes
encoding a coactosin-like protein, EhCoactosin, and a serine-rich E. histolytica protein
(SREHP) were identified in our screen. We utilized an independent genetic test to
strengthen the connection between SREHP or EhCoactosin, and PI3K signaling. The
assignment of these proteins as putative partners in PI3K signaling is novel. To our
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knowledge this is the first forward genetics screen adapted to reveal genes involved in the
PI3K pathway in this pathogen.
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CHAPTER 1
LITERATURE REVIEW

INTRODUCTION
Phosphoinositides, phosphorylated versions of phosphatidylinositol (PI), are a
major class of signaling phospholipids. PIs can be differentially phosphorylated at the 3',
4', or 5' positions of the inositol ring by kinases to yield seven possible phosphoinositides:
phosphatidylinositol 3-phosphate (PI3P), phosphatidylinositol 4-phosphate (PI4P),
phosphatidylinositol

5-phosphate

(PI5P),

phosphatidylinositol

3,4-bisphosphate

(PI(3,4)P2), phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), phosphatidylinositol 3,5bisphosphate (PI(3,5)P2), and phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3).
Conversely, the action of kinases can be regulated by phosphatases that dephosphorylate
phospholipids (1). Together, these phosphoinositides, and their respective kinases and
phosphatases regulate a diverse range of cellular functions including proliferation,
survival, cytoskeletal modifications, transcription, and vesicle trafficking (1).
Phosphoinositides can also mediate virulence in a variety of eukaryotic
pathogens. Little is known about phosphoinositide-signaling in Entameoba histolytica.
Therefore, in this review we will explore the role of phosphoinositides in virulence in
several protozoan parasites including Trypanosoma brucei, Trypanosoma cruzi, and
Leishmania spp. as well as in Entamoeba spp. Parasite phosphoinositides regulate cell
growth, morphology, survival and differentiation, encystation, vesicle trafficking, and
cell signaling. In addition, intracellular parasites have developed several strategies to
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modify host phosphoinositide signaling to invade and to evade host immune response.
Discerning the specific mechanisms adopted by parasites will provide us insight into
developing new drug therapies for successful disease management. The goal of this
review is to two-fold- 1) To examine the contribution of phosphoinositide signaling in
promoting virulence functions of protozoan parasites- Entamoeba spp., T. brucei, T. cruzi
and Leishmania spp. 2) To discern the mechanisms adopted by protozoan parasites,
specifically obligate intracellular parasites such as T. cruzi and Leishmania, to manipulate
host phosphoinositide signaling to enter the host, survive and propagate.

OVERVIEW
The variety of phosphoinositides found in the eukaryotic cells is regulated by PIkinases and, inositol phosphatases, such as phosphate and tensin homologue (PTEN) or
SH2 domain-containing inositol 5-phosphate (SHIP) (2). In other words, the synthesis of
different phosphoinositides involves complex and reversible interconversions as
demonstrated in Fig. 1. Importantly, the generation of phosphoinositides, and the
localization of the corresponding kinases and phosphatases, are precisely regulated in
time and space, leading to distinct, non-homogenous subcellular pools (1). These pools of
phosphoinositides further propagate signal by recruiting downstream signaling
molecules.
Phosphatidylinositol (PI)
PI is a ubiquitous eukaryotic phospholipid. Besides serving as the precursor for the
generation of other phosphoinositides, PI is essential for the synthesis of
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glycosylphosphatidylinositol (GPI), a lipid anchor that facilitates protein-lipid interaction.
The release of GPI-anchorage can be achieved by the action of phosphatidylinositolspecific phospholipase C (PI-PLC) (3).
PI is synthesized de novo by PI synthase (PIS) from myo-inositol and CDPdiacylglycerol (CDP-DAG) (4). An alternative route of PI synthesis includes head group
exchange between a pre-existing PI and free myo-inositol. myo-inositol can be acquired
by de novo synthesis from glucose-6-phosphate by the enzyme INO1, or by import via
inositol transporters (5).

Figure 1.1: Phosphoinositide metabolism. This figure shows all the possible
interconversions between the various phosphoinositides that exist in mammalian cells.
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Phosphatidylinositol 4-phosphate (PI4P)
PI4P can be generated either from PIs by PI4-kinases (PI4Ks) or from PI(4,5)P2 by 5phosphatases (6). PI4Ks can further be classified into type-II and –III enzymes based on
their activity, biochemical property, sequence, and inhibitor profiles (7). Furthermore,
there are two type-II PI4K isoforms- PI4KII-α and PI4KII-β and two type-III PI4K
isoforms- PI4KIII-α and PI4KIII-β. While type II-PI4K and PI4KIII-β function in
membrane trafficking in the secretory/endocytic pathway (7), PI4KIII-α synthesizes local
pools of PI4P that participate in phospholipase C-dependent signaling (8). Together, PI4P
and PI4Ks are essential for the maintenance of Golgi structure and in cytokinesis (6).
Phosphatidylinositol 5-phosphate (PI5P)
PI5P is synthesized from PI by PI5-kinases (PI5Ks) (9) and PIKFyve (10) or from
PI(3,5)P2 (11) and PI(4,5)P2 (12) by phosphatases. The cellular levels of PI5P increases
upon activation of the tyrosine kinase signaling pathway (13) or during cell invasion by
bacterial pathogens (14). PI5P localizes to nucleus and interacts with ING2, a nuclear
protein involved in apoptosis (15). Transient increase in the cellular levels of PI5P is
suggested to mediate T cell signaling, gene transcription, chemotaxis, vesicle trafficking
and chromatin rearrangement (14).
3' Phosphorylated phosphoinositides
Phosphatidylinositol 3-kinases (PI3Ks) are a class of enzymes that phosphorylate
the D3 hydroxyl group of the inositol ring to yield lipid products including PI3P,
PI(3,4)P2, and PI(3,4,5)P3 (1, 16). PI3Ks are divided into three classes, Class-I, -II and III, based on their substrate specificity, protein domain structure and mechanism of
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regulation (16). In vitro, the activity of class I PI3Ks generate PI3P, PI(3,4)P2 and
PI(3,4,5)P3 whereas in vivo, they exclusively yield PI(3,4,5)P3 (16). While class II PI3Ks
yield PI3P and PI(3,4)P2, class III PI3Ks (homologs of Saccharomyces cerevisiae
vacuolar protein sorting mutant, Vps34) preferentially phosphorylate PI to generate PI3P
(16). PI3P, PI(3,4)P2 and PI(3,4,5)P3, can further propagate a signal by interacting with
proteins harboring specific domains such as FYVE finger domains, which bind PI3P, and
pleckstrin homology (PH) domains, which bind PI(3,4,5)P3 and PI(3,4)P2 (17). The
activity of PI3K can be countered by the action of phosphatases such PTEN and SHIP
(2).
PI3Ks and their products are key regulators of endocytosis, vesicle trafficking,
and motility by modulating actin cytoskeletal arrangement and by activating downstream
signaling molecules. For example, during phagocytosis, class I PI3Ks accumulate at
early, forming phagosomal cups, where they rapidly and transiently phosphorylate
PI(4,5)P2 to PI(3,4,5)P3. PI(3,4,5)P3 recruits proteins that mediate cortical actin
rearrangement, necessary for phagosome formation. On the other hand PI3P, generated
by class III PI3K upon activation by Rab5, binds FYVE-domain-containing proteins,
such as early endosome antigen-1 (EEA1), and targets them to early phagosome (18).
During chemotaxis, PI(3,4,5)P3 accumulates at the leading edge of the cell (19) , resulting
in the activation of protein kinase B, which is also known as Akt. Akt phosphorylates and
activates downstream proteins resulting in actin polymerization and cytoskeletal
rearrangements promoting cellular movement (19). PI3K/Akt can also regulate various
other cellular functions including cell survival (20), CREB-mediated gene transcription
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(21), and allows cells to overcome cell cycle arrest in G1 and G2 (22, 23). Overall, proper
functioning of the cell relies on a balance between the activities of PI3K and
phosphatases, the failure of which leads to many human diseases such as chronic
inflammation, cancer, autoimmunity, and diabetes, other metabolic and degenerative
diseases (24).
PI(3,5)P2 is generated by the action of phosphatidylinositol 5-kinase, also known
as PIKFyve in mammalian cells (2) with PI3P as substrate. Although the endogenous
levels of PI(3,5)P2 are extremely low in eukaryotic cells, a sharp increase is observed
upon hyperosmotic stress (2).
PI(4,5)P2 and phospholipase C
Although majority of PI(4,5)P2 is synthesized from PI4P by the type I PI 4phosphate 5-kinases (PIP5K), there is evidence for synthesis of PI(4,5)P2 from PI5P by
type II PI4kinase (1). PI(4,5)P2 comprises >99% of all the doubly phosphorylated
phosphoinositides in mammalian cells (25), and acts as a link that connects the
actomyosin cytoskeleton to the plasma membrane. In eukaryotic cells, PI(4,5)P2 regulates
the strength of interaction between cytoskeleton and plasma membrane, which is required
for maintaining cell shape and integrity (26). PI(4,5)P2 acts as second messenger
molecules by binding to and recruiting various cytoskeleton remodeling proteins such as
α-actinin, spectrin, ERM family proteins (Ezrin, Radixin and Moesin), vinculin and talin
to the plasma membrane (27). PI(4,5)P2 initiates actin filament assembly through WASP
family proteins, decreases filament severing by binding and activating gelsolin family
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proteins and cofilin, promotes disassociation of plus-end capping proteins such as
gelsolin and CapG, and inhibits the actin monomer sequestering action of profilin (27).
Other lipid second messenger molecules can be generated from PI(4,5)P2. For
instance, phospholipase C can bind and hydrolyze PI(4,5)P2 to yield inositol triphosphate
(IP3) and diacylglycerol (DAG) (28, 29). While IP3 stimulates an increase in intracellular
calcium (Ca2+) levels (30, 31), DAG activates protein kinase C (PKC) (32). Like other
phosphoinositides, PI(4,5)P2 recruits proteins by interacting with specific lipid-binding
domains. Some of the known domains that bind PI(4,5)P2 include PH, ENTH, FERM,
and Tubby domains (25). There is also evidence for unstructured basic effector regions of
proteins (such as MARCKS) binding with high affinity to PI(4,5)P2 (25).
Entamoeba spp.
Entamoebae, a genus of Amoebazoa, are single-celled eukaryotes. E. histolytica is
the causative agent of amoebic dysentery and liver abscess, while E. dispar is harmless
and incapable of invading tissue. E. invadens is a reptilian parasite that, like E.
histolytica, can cause colitis and liver abscess in their reptilian hosts. Infection with E.
histolytica is mainly prevalent in developing countries that cannot prevent its fecal-oral
spread. E. histolytica enters the human host upon ingestion of environmentally stable
cysts in contaminated water or food. After passing through the stomach, excystation leads
to the release of trophozoites, which then migrate to the bowel for colonization. From
here, the parasite can enter two non-mutually exclusive routes of infection, noninvasive
or invasive disease (34). In the non-invasive disease, E. histolytica trophozoites re-encyst
in the lumen and exit the body through feces, resulting in the continuation of their life
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cycle. However, in 10% of the infected individuals, infection can progress from a noninvasive stage to an invasive stage (35), which is characterized by adhesion to and
destruction of colonic epithelium. The parasites now enter the circulatory system and
translocate to other organs. The most common site of extraintestinal infection is the liver,
characterized by the formation of amebic liver abscess.
Trypanosomatids
Trypanosomatids are kinetoplastid protozoa, characterized by the presence of a
single flagellum. The three major diseases in humans due to infection with
trypanosomatids include, African trypanosomiasis caused by Trypanosoma brucei,
Chagas disease caused by T. cruzi, and leishmaniasis caused by members of the
Leishmania species.
Trypanosoma brucei
T. brucei is the causative agent of Human African Trypanosomiasis (HAT) (also
known as African Sleeping Sickness) and Animal African Trypanosomiasis (AAT) (also
known as Nagana). While T. brucei rhodesiense and T. brucei gambiense infect humans,
T. brucei brucei is pathogenic to both wild and domestic animals. Together, HAT and
AAT are a major cause of rural underdevelopment in the impoverished regions of subsaharan Africa (36). T. brucei is an extracellular parasite that requires two hosts for the
completion of its life cycle- an insect tsetse fly vector and a mammalian host (36). An
infected tsetse fly injects highly infective metacylclic trypomastigotes into the skin of the
mammalian host. Here, the metacyclic parasites differentiate into long slender blood
stream form trypomastigotes and enter the circulatory system and divide by binary

8

fission. Blood stream form parasites express a dense layer of protective protein coat made
of the GPI-anchored variant surface glycoprotein (VSG). Although only one VSG variant
is expressed at a given time, the blood stream form parasites are capable of switching the
expression of the VSG coat protein. This antigenic variation allows the parasite to remain
undetected through the course of infection (37). When parasitemia reaches a high level in
blood, the slender blood stream form form begins to differentiate into stumpy, nonproliferative form that is pre-adapted for the midgut of the tsetse fly.
During a blood meal of the infective host, another tsetse fly ingests both the
slender and stumpy trypomastigotes. While the slender form of the parasite perish due to
the action of proteases, the stumpy trypomastigotes survive. In the midgut of the fly, the
parasites differentiate into procyclic trypomastigotes, where the VSG coat is replaced
with a procyclin coat. The procyclic form trypomastigotes multiply by binary fission. The
parasites leave the midgut, differentiate into epimastigotes and reach the fly’s salivary
gland. Here, the epimastigotes divide and differentiate into the highly infective
trypomastigotes, which reacquire the VSG coat, thus, completing their life cycle.
Trypanosoma cruzi
T. cruzi, the etiological agent of Chagas disease. An estimated 8 million people
are infected by T. cruzi with around 30-40% developing the symptomatic, and often lifethreatening Chagas disease (38). T. cruzi, like T. brucei, requires two hosts for the
completion of its life cycle (38). During a blood meal of the mammalian host, the
infected triatomine bug (insect host), defecates the highly infective trypomastigotes on
the wound site. The mechanism of trypamastigote entry into the host cells depends on the
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nature of the host (39). The parasite resides within the host in a endocytic vacuole known
as the parasitophorous vacuole which acquire lysosomal markers (40). The parasites
secrete lytic proteins, which disrupt the parasitophorous vacuole, and enable their escape
into the cytosol of the host. During this transition, the parasites differentiate into
amastigotes that are capable of replicating. Amastigotes transform into trypomastigotes,
and are released into the bloodstream. The trypomastigotes can once again invade a
variety of host cell and re-differentiate into amastigotes or enter the vector host during a
blood meal of the infected human host. In the insect gut, trypomastigotes differentiate
into epimastigotes and multiply by binary fission. From here, the parasites move to the
hindgut where they transform into the infective trypomastigotes. Thus, T. cruzi
developmental stages include the epimastigotes in the insect vector; the amastigotes
(intracellular form) that lives in the cytoplasm of the human host cells; and the highly
infective trypomastigotes that are capable of invading human host cells.
Leishmania spp.
Protozoa of the genus Leishmania are the causative agent of the disease
leishmaniasis. Approximately 12 million people are infected with this parasite worldwide
(41). Clinical manifestations of the disease include localized cutaneous leishmaniasis
(caused by L. major, L. tropica, L. braziliensis, and L. mexicana), mucosal leishmaniasis
(caused mainly by L. braziliensis) and visceral leishmaniasis (caused by L. donovani, and
L. infantum/L. chagasi) (42). Disease symptoms are exacerbated in HIV patients.
The parasites alternate between two developmental stages-the motile, flagellated
promastigote form and the non-motile amastigote form. All types of leishmaniasis are
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transmitted by female phlebotomine sandflies. The infective metacylic promastigotes are
injected into the mammalian host during a blood meal by the sandfly. Phagocytic cells
such as the macrophages, dendritic cells and neutrophils rapidly internalize these
promastigotes. In the parasitophorous vacuole of the phagolysosome within the host, the
promastigotes differentiate into amastigotes. The amastigotes divide rapidly in the
parasitophorous vacuole by binary fission, rupture the host cells and infect neighboring
cells. Amastigotes enter the sandfly vector during a blood meal of the infected host,
migrate to the insect midgut and undergo series of morphological changes and
differentiate into the infectious promastigote form. The promastigotes migrate to the
anterior midgut and foregut and are injected into another host.

PHOSPHOINOSITIDE

SIGNALING

IN

VIRULENCE

IN

PROTOZOAN

PARASITES
PI and GPI-anchor synthesis
Phosphatidylinositol (PI) functions as a precursor for the synthesis of signaling
phosphonositides and GPI anchors. GPI-anchored proteins in E. histolytica, T. brucei, T.
cruzi, and Leishmania have been shown to participate in virulence functions including
cell survival, adhesion to host and host extracellular matrix, immune evasion, and signal
transduction (43, 44). In T. brucei the pathway for PI generation from myo-inositol is
well established (45). The T. brucei INO1 enzyme (TbINO1) utilizes glucose 6phosphate to generate inositol 3-phosphate, which is then dephosphorylated to myoinositol (5). T. brucei, PI synthase (TbPIS) accounts for the generation of a vast majority
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of phosphatidylinositol from myo-insoitol in blood stream form parasites (46). The blood
stream form T. brucei has been shown to contain 2 pools of PIS, one pool in the ER that
utilizes endogenously synthesized myo-inositol, and another pool in the Golgi that
utilizes myo-inositol taken up from the environment (46, 47). The former pool of PIS is
preferentially used in the biosynthesis of GPI-anchor while the latter pool is used for the
generation of other phosphoinositides (46, 47). Importantly, depletion of TbPIS leads to a
significant reduction in GPI biosynthesis and cell survival indicating that the activity of
PIS and its product in T. brucei is essential (46). T. cruzi and L. donovani have been
shown to possess inositol transporters (45). However, it remains to be seen if T. cruzi, E.
histolytica, and Leishmania also require de novo PI synthesis for the production of GPIanchors and other phosphoinositides.
PI3K and 3'-phosphorylated phosphoinositides
There is a strong correlation between PI3K activity and virulence of eukaryotic
pathogens. For instance, expression of PI3K is higher in virulent E. histolytica than in
nonvirulent E. dispar (48). Small molecule inhibitors of PI3K, such as LY294002 and
wortmannin, have been employed to study the role of this enzyme and its products in the
pathogenesis of Entamoeba and trypanosomatids. Treatment of E. histolytica
trophozoites with wortmannin inhibits directional cell polarization (49), motility, actin
cytoskeletal rearrangements, proteolytic activity and the development of amebic liver
abscess in an animal model of disease (50). Exposure of trophozoites to either LY294002
(51) or wortmannin inhibits pinocytosis of a fluorescent fluid phase marker, FITCdextran (52), and disrupts phagocytosis (52-54), and adhesion to host cells in a dose-

12

dependent manner (54). Interestingly, treatment of E. invadens with wortmannin inhibits
encystation and thus, PI3K activity may also be essential for completion of the life cycle
in this genus.
Exposure of T. cruzi epimastigotes to wortmannin strongly decreases their cell
growth and induces defects in their ultrastructure (55). Specifically, the cells display
abnormal chromatin condensation that is reminiscent of apoptosis, formation of
autophagosomes and myelin-like figures, loose flagellar membrane with bleb formation,
and incomplete cell division (55). In addition, T. cruzi PI3K activity is essential for
invasion since exposure of trypomastigotes to wortmannin prior to infection strongly
inhibits their entry into host cells (56). NVP-BEZ235, an inhibitor of mTOR/PI3K is a
potent anti-trypanosomal agent, arrests T. brucei growth and reduces parasitemia in
animal models of T. b. rhodesiense infection, and has a high in vitro potency against T. b.
gambiense (57).
Similar to mammalian cells, there is evidence for modulation of vesicular
trafficking events by PI3K in trypanosomatids. Trafficking in trypanosomatids is highly
polarized with the entire uptake and secretory export directed through the flagellar
pocket, an invagination at the base of the flagellum. In T. brucei, endocytosis is not only
necessary for the uptake of nutrients but it also essential for the maintenance of VSG, and
for the removal of surface antibodies (58). This process is highly developmentally
regulated with the highest activity in the mammalian infective stages (59) and has been
deemed a necessary adaptation required for the survival of T. brucei in mammalian host
(60).
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Class III PI3K in T. brucei, TbVPs34, is essential for receptor-mediated
endocytosis.

The
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Importantly, knockdown of TbVps34 interferes with receptor-mediated endocytosis and
export of VSG (61). In T. cruzi, an overexpression of Vps34 abrogates receptor-mediated
endocytosis (62), further ascertaining the requirement of proper PI3K signaling in the
maintenance of endocytic functions in trypanosomes.
In other systems, Rab5 GTPases regulate the activation of Vps34 and the
subsequent production of PI3P at the endosome (18). Although Rab5 homologues are
essential for endosomal trafficking in T. brucei (63-65), the early endosomal antigen
(EEA1) that participates in the tethering of the endosome to phagosome through its
interaction with PI3P (66) is absent, suggesting the existence of a novel endosomal
mechanism. Recently, a Ras-like GTPase, TbFRP, with an N-terminal FYVE domain and
a F-box (a domain that is known to mediate protein-protein interaction) was shown to be
targeted specifically to the endomembrane region via binding of FYVE domain to PI3P
(67). Interestingly, TbFRP undergoes rapid proteolysis, resulting in the cleavage of
GTPase from FYVE domain followed by a rapid protein turnover. This suggests a novel
connection between endosomal function and PI-signaling in this pathogen.
An unusual Class I myosin, TbMyoI, has been identified and characterized in T.
brucei (68). TbMyoI contains a FYVE-domain that is thought to specifically target the
protein to the membrane by promoting its interaction with PI3P. Consistently, the authors
(68) observed that the blood stream form TbMyoI localizes to the endocytic pathway, and
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depletion of TbMyoI inhibits endocytosis and cell division, and eventually leads to cell
death. Similar targeting of myosin I motors via PI3P to the endocytic pathway may exist
in other kinetoplastids including Leishmania as there is evidence for existence of FYVE
domain-containing class I mysoins in their genome (68, 69). This suggests a novel
mechanism of vesicle trafficking mediated by PI3P-myosin motors.
An interesting role for TbVPs34 in T. brucei stems from the observation that
knockdown of TbVPs34 in the blood stream form parasites, leads to inhibition of Golgi
segregation and cytokinesis (61). Although no such observation was made for the T. cruzi
Vps34 orthologue, TcVPS34, it has been implicated in osmoregulation and stress
response in this pathogen. T. cruzi encounters severe changes in osmolarity during
progression through their life cycle. Therefore, this parasite has evolved a “Regulatory
Volume Decrease” (RVD) mechanism to overcome hyposmotic stress (70). RVD
involves an amino acid efflux, rise in intracellular Ca2+, and elimination of water by
contractile vacuole complex (70, 71). Overexpression of T. cruzi Vps34 orthologue,
TcVps34, causes an enlargement of contractile vacuole, and protects cells from
restriction of RVD by PI3K inhibitors, wortmannin and LY294000 (62). Further, a FYVE
domain containing membrane-associated cAMP-specific phosphodiesterase, TcrPDEC2,
is essential for osmoregulation (72, 73). Overall, these data support the role for PI3K and
its lipid product, PI3P, in mediating and recruiting proteins to regulate cell volume during
hyposomotic stress (62, 73).
In E. histolytica, the products of PI3Ks have been studied using GST- and GFPtagged versions of FYVE and PH domains (53, 54, 74). PI3P localizes to phagocytic cups
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(54, 74) as well as to a tunnel-like membrane that connects the plasma membrane and
phagosomes (74). In agreement, a proteomic analysis identified a class III PI3K,
EhVPs34, in E. histolytica phagosomes (75). PI(3,4,5)P3 localizes to both pseudopods
and early, forming phagosomes in E. histolytica trophozoites (53).
There are several unique differences in phagocytosis between E. histolytica and
mammalian cells. In mammalian cells, PI3P localizes to phagosomes only after
phagosomal sealing (76), where as in E. histolytica PI3P localizes both to newly sealed
phagosomes and to forming-phagosomal cups as well (54). In mammalian cells and yeast,
PI3P localizes to endosomes and multivesicular bodies (77). In contrast, PI3P does not
localize to endosomes in E. histolytica (54, 74). Mammalian Rab5 is found on early
endosomes that fuse transiently with phagosomes. This is followed by fusion of Rab7positive lysosome with the phagosome (18). However, E. histolytica Rab5 and Rab7 are
associated with a novel compartment known as the pre-phagosomal vesicle (78). Prephagosomal vesicle fuses with the internalized phagosome, thus, transferring its contents
that aid in phagosome maturation and acidification (78). Importantly, activity of PI3K is
necessary for the biogenesis of pre-phagosomal vesicle (78). Finally, the effector of PI3P,
EEA1, is absent in E. histolytica genome (74, 79, 80), suggesting a novel mechanism for
endosomal trafficking.
Eleven out of the twelve E. histolytica FYVE-domain-containing proteins
(EhFPs), possess RhoGEF, PH and FYVE domains (74). Among them, EhFP4 is
recruited to the phagocytic cup where it colocalizes with F-actin. This protein also
interacts with Rho/Rac GTPases and thus, may recruit machinery required for F-actin
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polymerization. Interestingly, EhFP4 showed stronger affinity for PI4P than PI3P,
suggesting that domains other than FYVE domain present in this protein may modulate
its phosphoinositide-binding capacity. Overall, these data suggest a role for PI3P, PI4P
and EhFP4 in phagocytosis in this pathogen.
E. histolytica also contains an unusually high amounts of PI(3,4,5)P3 at the
plasma membrane (53) as compared to mammalian cells. Unlike mammalian cells (81),
serum withdrawal from E. histolytica trophozoites does not affect this steady-state
PI(3,4,5)P3 levels (53), suggesting the existence of unique mechanism for regulating
PI(3,4,5)P3 synthesis and maintenance. Overexpression of a GFP-tagged PH domain from
Bruton’s tyrosine kinase (GFP-PHBtk), a PI(3,4,5)P3 biosensor, leads to alterations in
phosphoinositide signaling in this pathogen. Specifically, E. histolytica cell line overexpressing GFP-PHBtk exhibits reduced PI(4,5)P2 (82), and increased PI(3,4,5)P3 levels
(Koushik and Temesvari, unpublished). This cell line also displays a number of
phenotypic changes including reduced erythrophagocytosis, and increased motility (53),
and improper submembrane localization of the three subunits of the E. histolytica
adhesin, Gal/GalNAc lectin (82), as well as changes in gene expression (Koushik and
Temesvari, unpublished). Together, these data suggest that tight coordination of the
levels of PI(4,5)P2 and PI(3,4,5)P3 is necessary for proper functioning of the cell.
Autophagy, is a strategy utilized by eukaryotic cells to degrade and recycle
proteins and organelles, and is essential in various biological processes including
nutritional and stress response, immune response, differentiation and aging. The
autophagosome is a vesicular compartment that arises from the engulfment of organelles
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or proteins in the cytoplasm, which are destined to be degraded/recycled. Autophagy
relies on the activity of 2 ubiquitin-like protein conjugation systems-Atg8 and Atg12 and
culminates with the delivery of components of the autophagosomes to the lysosomes for
degradation (83). Autophagy requires the activity of Class III-PI3K (84, 85). The Atg8
conjugation system is functional in E. histolytica (86), E. invadens (86), T. brucei (87), T.
cruzi (88), L. major (89) and L. mexicana (90). Autophagy is upregulated during the
logarithmic growth phase and during encystation in E. invadens (86). Furthermore, PI3K
inhibitors reduces autophagy, cell growth and arrest encystation in E. invadens
suggesting a role in differentiation and proliferation of Entamoeba.
PI4P and PI4K
The T. brucei type III PI4-kinase β, TbPI4KIII-β, that generates majority of PI4P
in this pathogen, is required for endocytosis (91). Specifically, knockdown of PI4KIIIB
by RNAi causes mislocalization of lysosomal and flagellar pocket proteins, reflecting a
defect in sorting and/or trafficking (91). Depletion of TbPI4KIII-β also arrests cell
growth and cytokinesis, and distorts Golgi apparatus in the procyclic T. brucei (91).
TbPI4KIII-β and hence, PI4P, is required for maintenance of endocytosis Golgi structure,
normal cell shape and morphology, and cytokinesis (91).
PI(4,5)P2 and phospholipase C
In E. histolytica, PI(4,5)P2 localizes to cholesterol-rich microdomains, lipid rafts,
and the actin-rich fractions of the parasite membrane (92). Lipid rafts are specialized
microdomains that are known to organize signaling molecules participating in a variety of
virulence functions in protozoan parasites (93). Using a GST-tagged PH domain from
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PLCD1 that specifically binds PI(4,5)P2, it was demonstrated that the trailing edge
(uroids) of the polarized trophozoites are highly enriched in lipid rafts and their
constituent phosphoinositide, PI(4,5)P2. Polarization and enrichment of uroids and rafts
with PI(4,5)P2 are enhanced upon cholesterol treatment of E. histolytica trophozoites,
with a concomitant increase in intracellular Ca2+ and motility. In support, several actinbinding proteins that were identified in a proteomic study (94) of the uroids are also
known to bind PI(4,5)P2 and Ca2+ in other systems, and remodel the actin cytoskeleton to
enable cell movement. Overall, these data suggest that in E. histolytica, PI(4,5)P2 may
signal from lipid rafts and cholesterol may play a role in triggering PI(4,5)P2-mediated
signaling to enhance the motility of this pathogen
In E. histolytica, lipids rafts regulate parasite-host cells (95) and parasite-host
extracellular matrix interactions (96). There is also evidence for co-compartmentalization
of the three subunits of a well-characterized E. histolytica adhesin, Gal/GalNAc lectin, to
lipid raft fractions upon exposure to ligands such as human erythrocyes, and collagen
(82) or upon cholesterol-loading of the amoebic membrane (97). Specifically, this ligandinduced enrichment of the Gal/GalNAc lectin subunits in E. histolytica lipid rafts requires
both PI(4,5)P2 and Ca2+ suggesting a correlation between the submembrane localization
of lectin and phosphoinositide signaling in this pathogen.
PI(4,5)P2 also functions in mediating actin cytoskeletal changes that are required
to promote phagocytosis and vesicle trafficking in eukaryotic cells (98). A gene
synthesizing phosphatidylinositol 4-phosphate 5-kinase, is upregulated in phagocytosing
E. histolytica trophozoites (99). There is also evidence for participation of TbEpsinR,
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containing a putative phosphoinositide-binding ENTH domain, as an adaptor protein in
clathrin-mediated endocytosis in T. brucei (100). TbEpsinR participates in the uptake of
several surface receptors, including transmembrane and GPI-anchored proteins (100).
Although, ENTH domain proteins are known to bind PI(4,5)P2 or PI4P, it remains to be
seen whether the ENTH domain of TbEpsinR binds phosphoinositides in vitro and/or in
vivo.
Docampo et al. (101) were the first to demonstrate the existence of PI(4,5)P2 and
the products of its hydrolysis, IP3 and DAG, in T. cruzi. Treatment of T. cruzi
epimastigotes with the phospholipase C inhibitor, U73122, strongly reduces proliferation
(102). IP3 binds to the IP3 receptors (IP3R) and releases Ca2+ from intracellular Ca2+
stores. The IP3Rs characterized thus far, in trypanosomatids, seem to be essential for
trypanosomatid growth, infectivity (103, 104) and differentiation (104). T. brucei IP3R
localizes to acidocalcisome (103), and promotes release of Ca2+ from this organelle upon
stimulation.
T. brucei glycosyl-phosphatidylinositol-specific phospholipase C (TbGPI-PLC) is
present strictly in the blood stream form stage of the parasite, and cleaves the GPI-anchor
on the VSG to generate membrane-bound DAG and soluble VSG (3, 105). TbGPI-PLC
was shown to be nonessential since GPI-PLC null mutants do not display any growth
defects and can complete their life cycle (106). However, the null mutants exhibit
reduced parasitemia in infected mice (106). Interestingly, TbGPI-PLC is involved in the
endocytosis of transferrin (107). Subramanya et al. (107) demonstrated that TbGPI-PLC
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does not interact with the endosomal machinery directly but stimulates endocytosis via a
downstream secondary messenger, DAG.
T. cruzi Phospholipase C ( TcPI-PLC) hydrolyzes PI(4,5)P2 to yield IP3 and DAG.
Despite lacking a PH domain, TcPI-PLC possesses lipid modifications that enable its
plasma membrane localization (108). In particular, posttranslational modifications
including myristoylation and acylation are essential for targeting TcPI-PLC to the outer
surface of the plasma membrane (109, 110). These lipid modifications are also required
for the differentiation of trypamastigotes to amastigotes, an event that is necessary for
replication and propagation of the parasite (108, 109). Recently, it was shown that
expression of TcPI-PLC is developmentally regulated, with two peaks in surface
expression-one after the differentiation of trypomastigotes to amastigotes and the other
before differentiation of amastigotes into tryposmastigotes (111). Interestingly, the two
peaks in the TcPI-PLC expression correlates with reduction in the host cell PI(4,5)P2 and
an increase in IP3 and hence, may mediate downstream signaling in host.

HOST PHOSPHOINOSITIDE SIGNALING IN PARASITE PATHOGENESIS
Manipulation and regulation of host cell signaling pathways is a common strategy
adopted by microbial pathogens for successful invasion. Intracellular pathogens disrupt
host cellular processes to promote their internalization and survival. The mechanisms and
the route of entry vary with the type of parasite, the strain of parasite and the type of host
cell. T. cruzi and Leishmania are obligate intracellular parasites that are capable of
invading and replicating inside a wide variety of mammalian cells for completion of their
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life cycle. Both of these protozoan parasites have the ability to invade phagocytic and
non-phagocytic host cells (39, 112).
T. cruzi trypomastigotes, can enter non-phagocytic host cells by two actinindependent mechanisms-lysosome-mediated and plasma membrane-mediated. The
former relies on the recruitment of host lysosomes to the site of trypomastigote entry
(113), which delivers membrane for the formation of parasitophorous vacuole (114). The
latter involves invagination of host cell plasma membrane enriched in the products of
class I PI3K, enveloping the trypamastigotes in vacuoles that subsequently fuses with the
lysosomes (115). Activation of PI3K is key in the establishment of infection via either
pathway. First, lysosome-mediated entry of trypamastigotes is completely abolished by
treatment of host cells with PI3K inhibitors, wortmannin or LY294002 (115). Second,
even though trypamastigotes can enter the host through the plasma membrane-mediated
pathway, infection is severely abolished in the absence of PI3K activation (115, 116).
This defect was attributed to the exit of the parasites from the host (116) due to the
inability of their parasitophorous vacuoles to fuse with lysosomes (115, 116). Transient
residence in the lysosome is necessary for the rupture of the vacuole and release of
parasite into the cytosol of the host where they differentiate and propagate (117).
Therefore, a PI3K-dependent step is required for establishment of infection by T. cruzi in
nonphagoytic cells.
Additionally, T. cruzi utilizes host endocytic machinery that depends on PI3K, for
trafficking to the lysosome. This is demonstrated by the colocalization of a GFP-tagged
2XFYVE domain and EEA1 with T. cruzi-containing vacuoles following internalization
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of the parasite (115). Clathrin-mediated endocytosis has also been implicated in the
parasite entry process (118, 119). Inhibition of dynamin, a protein involved in clathrinmediated endocytosis, reduces internalization of T. cruzi by both phagocytic and nonphagocytic cells. Dynamin is a GTPase family protein that is recruited and anchored to
the plasma membrane by the binding of its PH domain to PI(4,5)P2 (120). Additionally,
inhibition of PI3K fails to recruit dynamin to the phagosome, implicating that dynamin is
downstream of PI3K-signaling (121). This PI3K-dependent dynamin recruitment and
activation is essential for the formation of parasitophorous vacuole by host cells (118).
Recently, Barrias et al. (122) reported an alternative route of entry via macropinocytosis,
where there is a coloclaization of the PI3P-binding macropinocytosis marker, rabankyrin5, to the parasitophorous vacuole.
Entry into professional phagocytes such as macrophages, takes place through
phagocytosis, a process that relies heavily on actin remodeling. Phosphorylation of
protein tyrosine kinase recruits PI3K to the site of attachment of T. cruzi to macrophages
(128). This is thought to promote actin microfilament assembly at the parasitemacrophage interphase (128). Although entry of Leishmania promastigotes and
amastigotes into professional phagocytes takes place through phagocytosis, it remains to
be seen whether this parasite engages similar protein tyrosine kinase-dependent PI3K
activation. However, a study by Gagnon et al. (129) suggested that endoplasmic
reticulum (ER)-mediated phagocytosis is a possible mode of entry of Lesihmania into
macrophages and this mechanism requires the activity of PI3K.
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Host cell phosphoinositide signaling pathways can be utilized for regulating one
or more of the following functions involved in the successful establishment of infection1) actin cytoskeletal remodeling to aid parasite entry, 2) modulation of vesicle trafficking
events in host, 3) protection of infected host from apoptosis, and 4) subversion of host
immune response.
Actin cytoskeleton remodeling
Once inside the host, T. cruzi increases the surface expression of phospholipase C
(TcPI-PLC) during differentiation (111). The release of TcPI-PLC hydrolyses host
PI(4,5)P2, and the resulting IP3-dependent Ca2+ signaling events thought to perturb actin
stress fiber assembly, vimentin filaments, all of which may play a role in regulation of
gene expression and host cell signaling (111, 131, 132).
Protection of infected host from apoptosis
One key survival strategy that intracellular obligate parasites employ is blocking
of host cell apoptosis pathway. This process often involves activation of PI3K/Akt. In
support of this, binding of T. cruzi trans-sialidase family of surface proteins activates
PI3K/Akt signaling in neuronal cells and triggers antiapoptotic mechanisms (133).
Similarly, infection of macrophages with L. major, L. pifanoi, and L. amazonensis
stimulates PI3K/Akt pathway leading to phosphorylation and inactivation of the substrate
of Akt, Bad, a proapoptotic molecule (134). Ruhaland et al. (134), also demonstrated that
the inhibition of PI3K/Akt pathway, with the inhibitors of PI3K or by knockdown of Akt,
results in apoptosis of the infected macrophages, further confirming that PI3K signaling
is essential for survival of host cells.
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Subversion of host immune response
Leishmania can evade host-protective response by either suppressing or
promoting the production of pro-inflammatory and anti-inflammatory cytokines,
respectively. For example, T helper (Th) 1-mediated responses are protective against
leishmania and elicit the production of pro-inflammatory cytokines such as IL-12, IL-18,
IL-1, IL-6, INF-γ and TNF-α (135). Conversely, Th2-mediated response favors the
production of IL-10 and IL-4 and causes disease progression (135). Accordingly,
C57BL/6 mice, which preferentially mount a Th1 response, can clear Leishmania
effectively. In contrast, BALB/c mice, which predominately mount Th2 response are
susceptible to Leishmania.
There is increasing evidence substantiating the regulation of host cell PI3K
pathway by Leishmania in order to manipulate host immune response that would be
advantageous to the parasite. Infection of macrophages with either L. major, L. pifanoi, or
L. amazonensis promastigotes promote antiapoptotic signaling via activation of PI3K/Akt
(134). Similar stimulation of PI3K/Akt was seen in L. donovani-infected macrophages
(136). Specifically, Akt activates the transcription factor, cAMP response element
binding protein (CREB), resulting in the expression of IL-10 (136). L. infantum-infected
dendritic cells do not mature and hence, do not elicit a strong anti-leishmanial immune
response (137). As in the case of macrophages, the infected dendritic cells display an
activated PI3K/Akt pathway. Importantly, pre-treatment of dendritic cells with PI3K
inhibitor, prior to infection with L. infantum, promotes the transcription of T-cell co-
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stimulator, CD40, and proinflammatory molecules, IL-12 and IL-6, and a strong
repression of IL-10 (137).
Similarly, macrophages (138) and dendritic cells (139) display PI3K/Aktdependent downregulation of IL-12 upon infection with L. amazonensis and L. major,
respectively. Remarkably, this effect can be reversed in PI3K-/- mice on a BALB/C
background where the mice mount a strong, and protective Th1 response and resist L.
major infection (139). Accordingly, PTEN phosphatase-deficient mice on C57BL/6
background show suppressed IL-12 production, and an increased IL-10 production, and
fail to efficiently clear the parasites (140).
Mice carrying an inactivation mutation in the class IA PI3K catalytic subunit,
p110δ, are very resistant to L. major infection, but with diminished Th1 and Th2 immune
response and a reduced production of INF-γ and TNF cytokines (141). The resistance
phenotype observed in p110δ mutant mice is contributed to defects in homing, expansion
and/or the function of regulatory T cells (Tregs). Tregs are an important source of IL-10
and act by decreasing the immune function. Liu et al. (141) suggest that in the absence of
Tregs, a weak Th1 response is sufficient to contain the parasite. A later study conducted
by the same group (142) demonstrated that the p110δ mutant mice healed from the
primary infection displayed an impaired secondary memory and were incapable of
controlling secondary Leishmania infection. Two distinct subset of memory T cells existthe central memory T cells (Tcms) and the effector memory T cells (Tems) (143). These
play a central role in countering challenge by an antigen that the cells have previously
encountered. Tcms are capable of self-renewal and remain in the secondary lymphoid
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organs by overexpressing a surface adhesin, CD62L (L-selectin). Tcms can differentiate
into Tems, suppress the expression of CD62L, and exit the lymphoid organs. Tems
produce effector cytokines such as IFN-γ upon challenge, and migrate to infected tissues
to promote effector functions. Importantly, Tems are critical in generating rapid and
efficient response to secondary infection. However, the lack of a functional p110δ in
mice infected for the second time with L. major, renders the effector T cells incapable of
downregulating their CD62L production and therefore, fail to effectively migrate to the
site of infection. The authors further suggest that manipulating PI3K pathway may be a
good methodology to generate desired T memory cell subset and/or response to
vaccination (142).
PI3Kγ, a class IB PI3K, is required for pathogenesis of cutaneous leishmaniasis
(144). The treatment of mammalian macrophages or neutrophils with a PI3Kγ-specific
small inhibitor, AS-605240 enhances the resistance to L. mexicana. Similarly,
macrophages and neutrophils derived from PI3Kγ-deficient mice stain display significant
suppression of parasite entry. The authors (144) attribute this resistance phenotype to the
impairment of Th2-mediated cytokine (IL-4 and IL-10) production and to the inability of
cells to recruit Tregs, to the site of infection upon inhibition of PI3Kγ signaling. Thus,
this study also demonstrates the potential of AS-605240 as an anti-leishmanial
therapeutic (144, 145).
Modulation of vesicle trafficking events in host
Manipulating vesicular trafficking mechanisms enables intracellular parasites to
reside in favorable environment within in the host. For example, L. donovani
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promastigotes inhibit the maturation of parasite-containing phagosomes compartment as
seen by impaired recruitment of Rab7 and lysosomal markers (146). This arrest in
phagosome maturation is characterized by build up of periphagosomal F-actin (147), and
retention of actin-polymerizing proteins including WASP, α-actinin, Arp2/3, Myosin II,
Cdc42, Rac1 and RhoA (148). In particular, the actin-binding proteins, WASP, α-actinin,
and Arp2/3 are recruited to the plasma membrane by binding to PI(4,5)P2 (27, 98). Thus,
the parasite-containing phagosome may engage host PI(4,5)P2 to modulate host
ctoskeleton. Importantly, this accumulation of F-actin is thought to interfere with the
signaling events leading to the fusion of lysosomes with the promastigotes-containing
phagosomes, thus, evading the microbicidal properties of the phagolysosome (148).
T. cruzi trypomastigotes promote their uptake by macrophages by engaging Tolllike receptor 2 (TLR2) (149), which recognizes and binds GPI- anchors or GPILs on the
parasite surface (150). Binding of the parasite stimulates PI3K-mediated Akt
phosphorylation and subsequent Rab5 activation that is essential for parasite entrance
into and replication within the macrophages.

PHOSPHOINOSITIDE KINASES AS DRUG TARGETS
Existing drug treatments against protozoan pathogens have several disadvantages.
For instance, the drugs currently used for disease control are reported to have severe side
effects and/or are difficult to administer (151, 152). Moreover, with the emergence of
drug-resistant strains of different parasites there is a growing urgency for development of
novel drug therapies (153, 154). Given the importance of phosphoinositide kinases in
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virulence and maintenance of parasite cellular functions, several studies have
demonstrated that kinases could serve as excellent anti-parasitic drug targets (155, 156).
Importantly, there is a large difference in the amino acid sequence of phosphoinositide
kinases between humans and protozoan parasites, which may further prove to be useful in
specifically increasing the selectivity of inhibitory compounds (156).
Recently, inhibitors of the members of the TOR/PI3K family were identified as
potential anti-trypanosomal drugs (57). Diaz-Gonzalez et al. (155) utilized a “therapeutic
repurposing” approach to test the efficacy of existing small molecule PI3K inhibitors that
are in clinical and pre-clinical development for cancer treatment, on the growth and
control of Trypanosoma spp. and Leishmania spp. These inhibitors strongly arrested
parasite growth in all the species/strains that were tested. In particular, compound NVPBEZ235, was potent in sub-nanomolar concentrations and cleared parasitemia in T.
brucei rhodensiense-infected animal models (155). Although the precise mechanism of
TOR/PI3K inhibition needs to be understood, the results from this study offer promising
possibilities for anti-trypanosomal drugs.
Several studies have also investigated the influence of existing drugs on
modulating host PI3K pathway. Sodium antimony gluconate (SAG), a pentavalent
antimony complex, is used in the treatment of leishmaniasis. SAG induces the generation
of reactive oxygen species (ROS) and nitric oxide (NO) in murine macrophages, and
thus, enables effective killing of intracellular L. donovani amastigotes (157). Basu et al.
(157) demonstrated that SAG induces activation of PI3K that triggers ERK-dependent
ROS generation and p38MAPK-dependent NO generation. The PI3K-dependent
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activation of p38MAPK pathway also promotes the generation of proinflammatory TNFα that furthers controls parasite replication and propagation. Miltefosine, an alkylphosphocholine drug, is a widely used as antiparasitic and anticancer agent (158). Among
the many modes of antileishmanial mechanisms that were discovered, treatment of L.
donovani-infected macrophages with miltefosine was demonstrated to induce a PI3Kmediated activation of p38MAPK pathway and induction of anti-leishmanial response
(159).
Finally, inhibition of host PI3K may prove to be a good strategy to prevent
disease progression and infection. Host cells are less susceptible to infection by parasite
species causing cutaneous leishmaniasis upon inhibition of either PI3Kδ (141) or PI3Kγ
(144). Therefore, the use of small molecule inhibitors tailored to inhibit specific PI3K
isoforms of the host may be a promising therapeutic treatment for managing disease due
to obligate intracellular pathogens. For instance, treatment of mammalian macrophages or
neutrophils with a PI3Kγ-specific small inhibitor, AS-605240 enhances the resistance to
L. mexicana (144). Moreover, the effectiveness of AS-605240 to decrease parasite burden
in mice is as good as that of the existing antileishmanial drug, sodium stibogluconate.
The authors (144, 145) also demonstrated the potential for developing combination
therapies, i.e., coupling the standard chemotherapy with PI3Kγ-isoform selective
inhibitor, to treat leishmaniasis may be a viable option for disease control.
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CONCLUSIONS
It is increasingly clear that both parasite and host phosphoinositide signaling are
important for virulence of eukaryotic pathogens. Phosphoinositides are essential for
modulating several key cellular functions, and hence, manipulating host cell
phosphoinositide signaling is very advantageous to obligate intracellular pathogens.
These pathogens utilize host phosphoinositides to establish successful infection in many
different ways. For instance, phosphoinositide-mediated actin cytoskeleton remodeling at
the site of entry aids in their uptake by host cells. Similarly, modulating host vesicle
trafficking events to ensure survival within parasite-containing vacuole, subverting host
immune response, and providing protection to host cells from apoptosis, ensures survival
and propagation of parasites. In addition, parasite phosphoinositide-metabolism is also
essential for their growth, division, cell cycle completion, endocytosis, response to stress,
motility, and evasion of host immune response. Finally, developing chemotherapeutics to
specifically target host and parasite phosphoinositide kinases could be useful in altering
parasite infectivity and boosting host defensive response. Overall, understanding the
different strategies utilized by eukaryotic pathogens to regulate host phosphoinositide
signaling and discerning the parasite phosphoinositide metabolism will improve our
knowledge of parasite pathogenesis.
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ABSTRACT
Entamoeba histolytica is an intestinal protozoan parasite and is the causative
agent of amoebiasis. During invasive infection, highly motile amoebae destroy the
colonic epithelium, enter the blood circulation, and disseminate to other organs such as
liver, causing liver abscess. Motility is a key factor in E. histolytica pathogenesis, and this
process

relies

on

a

dynamic

actomyosin

cytoskeleton.

In

other

systems,

phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] is known to regulate a wide variety of
cellular functions, including signal transduction, actin remodeling, and cell motility.
Little is known about the role of PI(4,5)P2 in E. histolytica pathogenicity. In this study,
we demonstrate that PI(4,5)P2 is localized to cholesterol-rich microdomains, lipid rafts,
and the actin-rich fractions of the E. histolytica membrane. Microscopy revealed that the
trailing edge of polarized trophozoites, uroids, are highly enriched in lipid rafts and their
constituent lipid, PI(4,5)P2. Polarization and enrichment of uroids and rafts with PI(4,5)P2
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were enhanced upon treatment of E. histolytica cells with cholesterol. Exposure to
cholesterol also increased intracellular calcium, which is a downstream effector of
PI(4,5)P2, with a concomitant increase in motility. Together, our data suggest that in E.
histolytica, PI(4,5)P2 may signal from lipid rafts and cholesterol may play a role in
triggering PI(4,5)P2-mediated signaling to enhance the motility of this pathogen.

INTRODUCTION
The intestinal parasite Entamoeba histolytica is known to cause amoebic
dysentery and liver abscess. E. histolytica enters the human host via contaminated food or
water as an environmentally stable cyst. Excystation leads to the release of trophozoites
in the small intestine, which colonize the bowel lumen. From here, the parasite can enter
two non-mutually exclusive routes of infection, noninvasive or invasive disease
(reviewed in reference 1). In the noninvasive mode, the trophozoite encysts and exits the
host, whereas in the invasive mode, the parasite adheres to and destroys the colonic
epithelium and enters the circulatory system. This results in extraintestinal infection, of
which amoebic liver abscess (ALA) is the most common manifestation. Motility is a key
virulence function that enables this parasite to cause extraintestinal infection (2).
Motile amoebae display a polarized morphology with a pseudopod at the leading
edge and a uroid (also referred to as a uropod in other eukaryotic cells) at the trailing
edge. A key feature of a polarized cell is the differential distribution of proteins and
lipids, including cell surface receptors, signaling molecules, and cytoskeletal elements.
For example, the pseudopod of E. histolytica is enriched in F actin, myosin IB (3, 4), and
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signaling molecules like phosphatidylinositol-3,4,5-trisphosphate [PI(3,4,5)P3] (5), while
the uroid is enriched in myosin II and signaling molecules, including an important
heterotrimeric adhesin, the galactose/N-acetylgalactosamine (Gal/GalNAc) lectin (6), F
actin, and various actin-binding proteins (7–9). Such spatial asymmetry helps the cells to
generate the necessary forces that are required for migration. For example,
polymerization of actin at the leading edge facilitates pseudopod extension. Concurrently,
adhesion molecules establish new focal contacts with the substrate, while activation of
myosin II motors generates the contractile force required for the detachment of existing
focal adhesions at the uroids. Together, these activities result in a net forward movement
of the cell body. Consequently, motility in this pathogen has been attributed to its highly
dynamic actomyosin cytoskeleton, which promotes the rapid morphological changes
required for cell movement (reviewed in reference 10).
Phosphoinositides act as links that connect the actomyosin cytoskeleton to the
plasma membrane. In other systems, phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2]
regulates the strength of the interaction between the cytoskeleton and the plasma
membrane, which is required for maintaining cell shape and integrity (11). PI(4,5)P2
belongs to a group of phosphorylated phosphoinositides that act as second messenger
molecules by binding to and modulating the activity of various cytoskeleton remodeling
proteins. Furthermore, other lipid second messenger molecules can be generated from
PI(4,5)P2. For instance, the pleckstrin homology (PH) domain of phospholipase C delta 1
(PLCD1) can bind PI(4,5)P2. PLCD1 hydrolyzes PI(4,5)P2 to yield inositol triphosphate
(IP3) and diacylglycerol (DAG) (12, 13). While IP3 stimulates an increase in intracellular
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calcium (Ca2+) levels (reviewed in references 14 and 15), DAG activates protein kinase C
(PKC) (reviewed in reference 16). PI(4,5)P2 can be phosphorylated by phosphoinositide
3-kinases (PI3Ks) to yield yet another signaling molecule, PI(3,4,5)P3 (reviewed in
reference 17). All of these signaling molecules, PI(4,5)P2, PI(3,4,5)P3, IP3, DAG, and
Ca2+, can interact with other effector proteins to trigger downstream signaling events.
In mammalian cells, PI(4,5)P2 is localized to lipid rafts (18–20). Rafts are
specialized membrane microdomains that are cholesterol and sphingolipid rich and are
known to organize signaling molecules that participate in a variety of cellular functions,
including cell polarization (21, 22), endocytosis (reviewed in reference 23), secretion
(reviewed in reference 24), and adhesion (25). Previously, E. histolytica was shown to
possess lipid rafts that regulate parasite-host interaction (26, 27). Disruption of rafts with
cholesterol-binding agents like methyl-β-cyclodextrin (MβCD) inhibits adhesion of E.
histolytica to host cells (26) and host extracellular matrix components (27). On the other
hand, cholesterol loading of amoebic membranes results in enhanced adhesion to host
cell monolayers, as well as cocompartmentalization of the three subunits of the
Gal/GalNAc lectin in lipid rafts (28).
Whether PI(4,5)P2 localizes to rafts in E. histolytica has not been previously
studied. Therefore, in the current study, we developed a PI(4,5)P2 biosensor and utilized
antibody to PI(4,5)P2 to study its subcellular and submembrane localization, respectively.
We demonstrate that PI(4,5)P2 localizes to rafts in E. histolytica and may signal from the
raft membrane domain to regulate cell motility.
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MATERIALS AND METHODS
Strains and culture conditions. Entamoeba histolytica trophozoites (strain HM-1:1MSS)
were cultured axenically in TYI-S-33 medium (29) in 15-ml glass screw-cap tubes at
37°C.
Exposure to cholesterol or methyl-β-cyclodextrin. The source of cholesterol used was a
bovine cholesterol concentrate (Creative Laboratory Products, Inc., Indianapolis, IN). In
all cases, to control for extracellular sources of cholesterol, trophozoites were incubated
in serum-free medium (TYI-S-33) for 30 min at 37°C prior to experimentation. After
serum starvation, trophozoites were incubated in serum-free medium supplemented with
0 to 3 mg/ml cholesterol or 50 mM methyl-β-cyclodextrin (MβCD; Sigma-Aldrich, St.
Louis, MO) for 15 or 60 min at 37°C. Cells treated with 0 mg/ml cholesterol represented
the untreated controls for all experiments.
Lipid raft isolation, lipid extraction, and lipid dot blots. Isolation of a Triton X-100resistant membrane and resolution of a detergent-resistant membrane (DRM) by sucrose
gradient density centrifugation were carried out as previously described (26). Extraction
of lipids from the sucrose gradient membrane fractions was carried out as described
previously (30). Briefly, methanol–12.1 N HCl (10:1) was added to each fraction at a
volumetric ratio of 1:1, and chloroform was added at a volumetric ratio of 2:1 (solventmembrane fraction) to facilitate phase separation. The organic phase was subsequently
extracted with the addition of methanol–1 N HCl (1:1) at a volumetric ratio of 1:1. The
organic phase was vacuum dried, and the pellets were used for lipid dot blot analysis.
Specifically, lipids were spotted onto a Hybond-C nitrocellulose membrane. The
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membrane was blocked in 1.5% (wt/vol) fatty acid-free bovine serum albumin (BSA) at
room temperature for 1 h and probed with mouse anti-PI(4,5)P2 antibody (1:1,000
dilution; Abcam, Cambridge, MA), followed by incubation with secondary antibody,
peroxidase-conjugated

goat

anti-mouse

IgG

(1:2,000

dilution;

Cappel,

ICN

Pharmaceuticals, Costa Mesa, CA). Immunoblots were visualized using an enhanced
chemiluminescence Western blotting detection system (Pierce Biotechnology, Rockford,
IL) according to the manufacturer's instructions. Semiquantitative densitometric analyses
of immunoblots were performed using ImageJ software (version 1.42q; National
Institutes of Health, Bethesda, MD). The net densitometry values were corrected to
reflect the differences in membrane fraction volume. Whole-cell lipid extraction and lipid
dot blot analyses were performed as previously described (31).
Generation of GST-tagged PHPLCD1 recombinant protein. The cDNA encoding the PH
domain from PLCD1 (PHPLCD1) was amplified from pEGFP-N1 (SignaGen Laboratories,
Gaithersburg,

MD)

by

PCR

using

GGAATTCATGGACTCGGGCCGGGAC-3′

the

following
and

primer

pair:

5′5′-

GGTCGACTCCTTCAGGAAGTTCTGCAG-3′. The resulting PCR product was cloned
into the pCR2.1-TOPO plasmid (Invitrogen, Carlsbad, CA). The DNA sequence
encoding PHPLCD1 was excised from pCR2.1-TOPO using EcoRI and SalI endonucleases
and was ligated into the polylinker region downstream of and in frame with the sequence
encoding glutathione S-transferase (GST) in the pGEX-5X-1 expression vector
(Amersham Biosciences, Piscataway, NJ). The authenticity of the DNA construct was
confirmed using restriction enzyme analysis and sequencing. Recombinant GST and
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GST-PHPLCD1 proteins were obtained by expression in Escherichia coli BL21
(Amersham, Piscataway, NJ) according to the manufacturer's protocol. To assess the
purity of the eluted proteins, SDS-PAGE and silver staining were carried out as
previously described (32). To validate the GST tag, Western blotting was performed as
described previously (33) using an anti-GST antibody (Chemicon, Temecula, CA) at a
dilution of 1:10,000.
Protein-lipid overlay assay. A protein-lipid overlay assay was carried out to assess the
PI(4,5)P2 binding capability of the GST-PHPLCD1 fusion protein as described previously
(34). Briefly, 1.6 to 100 pmol of phosphoinositides (Echelon Biosciences Inc., Salt Lake
City, UT), including phosphatidylinositol 3-phosphate (PI3P), phosphatidylinositol 4phosphate (PI4P), phosphatidylinositol 5-phosphate (PI5P), phosphatidylinositol 3,4bisphosphate

[PI(3,4)P2],

phosphatidylinositol

3,5-bisphosphate

[PI(3,5)P2],

phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2], and phosphatidylinositol 3,4,5triphosphate [PI(3,4,5)P3], was spotted on a Hybond-C nitrocellulose membrane. The
membrane was dried for 1 h at room temperature and incubated in blocking buffer
containing 2% (wt/vol) fatty acid-free BSA in Tris-buffered saline (TBS)–Tween (50
mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% [vol/vol] Tween 20) at room temperature for
1 h. The membrane was incubated overnight at 4°C in blocking buffer containing 0.2
µg/ml of either GST or GST-PHPLCD1, washed in TBS-Tween, and incubated in
polyclonal anti-GST antibody (1:10,000 dilution) in blocking buffer for 1 h. The
membrane was washed, incubated in horseradish peroxidase (HRP)–anti-rabbit IgG
(1:5,000 dilution) in TBS-Tween for 1 h, and then washed and developed as described
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previously (33).
We also tested the ability of GST or GST-PHPLCD1 to bind E. histolytica cell
extracts. Whole-cell protein extracts of trophozoites (5 × 105 and 1 × 105 cells) were
resolved by SDS-PAGE and electroblotted onto a nitrocellulose membrane. The
membrane was washed twice with distilled water and dried for 1 h at room temperature.
Serial dilutions of PI(4,5)P2 were spotted on one edge of the same membrane, which
served as a positive control for binding of the probe. The membrane was dried and
incubated with blocking buffer containing 2% (wt/vol) fatty acid-free BSA in TBSTween (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% [vol/vol] Tween 20), followed by
incubation with 0.2 µg/ml of either GST or GST-PHPLCD1 probes in the blocking buffer,
as described above. The membrane was washed in TBS-Tween and incubated in
polyclonal anti-GST antibody (1:10,000 dilution) in blocking buffer, followed by
incubation with HRP–anti-rabbit IgG (1:5,000 dilution) in TBS-Tween, and then washed
and developed as described previously (33). As a positive control for protein transfer, the
membrane was incubated in anti-actin monoclonal antibody (1:2,500 dilution; Abcam)
for 1 h. The membrane was washed, incubated in HRP–anti-mouse IgG (1:2,000 dilution)
in TBS-Tween for 1 h, and then washed and developed as described previously (33).
Biosensor staining and fluorescence microscopy. For fluorescence microscopy, E.
histolytica trophozoites were plated on a chambered cover glass slide system (Lab-Tek,
Christchurch, New Zealand) and fixed with 4% (vol/vol) paraformaldehyde overnight at
37°C. Cells were washed in phosphate-buffered saline (PBS), incubated in 50 mM NH4Cl
in PBS for 15 min, and then permeabilized with 0.05% (wt/vol in PBS) saponin for 10
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min as previously described (35). All subsequent buffers contained 0.05% (wt/vol in
PBS) saponin. This regimen preserves the cellular morphology and permeabilizes cells
without removing phosphoinositides from the plasma membrane (5, 35). Cells were
blocked with 10% (vol/vol) fetal bovine serum (FBS)–PBS and stained with
approximately 10 µg/ml of either affinity-purified GST or GST-PHPLCD1, followed by
staining with Alexa Fluor 488-conjugated rabbit anti-GST antibody (1:2,000; Invitrogen)
or Texas Red-conjugated goat anti-GST antibody (1:1,000; Rockland Immunochemicals,
Gilbertsville, PA), as described previously (35). Stained cells were viewed using a Nikon
Eclipse TI-E spectral confocal microscope (Nikon Instruments Inc., Lewisville, TX) or an
LSM510 confocal microscope (Carl Zeiss MicroImaging, Thornwood, NY). Images were
analyzed using Nikon NIS Elements or LSM Image Browser software, respectively. To
assess the effect of cholesterol on localization of PI(4,5)P2, cells were exposed to either 0
or 3 mg/ml cholesterol for 1 h and then fixed and stained as described above.
For lipid raft staining, E. histolytica trophozoites were fixed with 4% (vol/vol)
paraformaldehyde overnight at 37°C. Dialkyindocarbocyanine (DiIC16; Invitrogen)
staining of lipid rafts was carried out as described previously (27).
To determine if PI(4,5)P2 and lipid rafts localized to uroids, capping was induced
by incubation of amoebae with Alexa Fluor 488-conjugated concanavalin A (ConA;
Invitrogen) for 1 h on ice, followed by incubation on cover glass chambered slides for 15
min at 37°C as described previously (6). PI(4,5)P2 or lipid raft staining was carried out as
described above.
Measurement of motility. To test the effect of cholesterol on parasite motility, a motility
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assay was employed according to the methods of Zaki et al. (36). Briefly, cells were
serum starved for 30 min at 37°C and exposed to a range of cholesterol concentrations (0
to 3 mg/ml) in serum-free medium for 30 min at 37°C. Eight milliliters of complete TYIS-33 medium supplemented with 0.75% (wt/vol) agarose was poured into 60-mm petri
dishes and allowed to solidify at room temperature. A trough (2 by 30 mm) was cut into
the solidified medium to serve as the motility chamber. Following exposure to
cholesterol, trophozoites (5 × 105) were placed in the trough of the motility chamber. A
coverslip (22 by 40 mm) was placed over the trough and the plate was incubated at 37°C
for 3 h in 5% CO2. Images were captured using confocal microscopy. The migration
distance was measured using Zeiss LSM510 image analysis software.
Measurement of intracellular Ca2+ levels. To measure the effect of cholesterol treatment
on intracellular Ca2+ levels, a Ca2+ assay was employed as described previously (31).
Briefly, cells were incubated in serum-free medium supplemented with the fluorescent
Ca2+ indicator Fluo-4/AM (Invitrogen) or dimethyl sulfoxide (DMSO; diluent control) for
30 min at 37°C. Then, cells were incubated with a range of concentrations of cholesterol
(0 to 3 mg/ml) for either 15 min or 1 h at 37°C. Subsequently, 1 × 105 trophozoites were
pipetted into the wells of an uncoated 96-well plate, and after 5 min the plates were
transferred to a fluorescence microplate reader for 30 min. To account for the background
fluorescence, the fluorescence values for cells incubated in DMSO were subtracted from
the fluorescence values for cells incubated in Fluo-4/AM. The fluorescence value of the
untreated control cells at the 35-min time point was arbitrarily set equal to 100%, and the
values at other time points were reported as a percentage of this value.
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Statistical analyses. All values are given as means ± standard deviations (SDs) of at least
3 trials. To compare means, statistical analyses were performed using GraphPad Instat
v.3 software with an unpaired t test, Welch corrected (two-tail P value), or with one-way
analysis of variance (ANOVA) and a Tukey-Kramer multiple-comparison test. In all
cases, P values of less than 0.001 were considered highly statistically significant, while P
values of less than 0.01 or 0.05 were considered statistically significant.

RESULTS
PI(4,5)P2 compartmentalizes in lipid rafts and actin-rich pellet fractions of the DRM in
E. histolytica. In mammalian cells, PI(4,5)P2 has been shown to localize to lipid rafts (18,
19). Therefore, we determined if E. histolytica exhibits similar compartmentalization of
PI(4,5)P2. The detergent-resistant membrane (DRM), which consists of lipid rafts and the
actin-rich membrane, was isolated as described previously (26). Sucrose gradient density
centrifugation was used to resolve these two membrane types. Total phosphoinositides
were extracted from each of the gradient fractions and subjected to a lipid dot blot
analysis using antibodies to PI(4,5)P2 (Fig. 2.1 A). We previously demonstrated that
membrane fractions 9 to 14 possess high levels of cholesterol and contain lipid rafts (31).
Less buoyant fractions (fractions 17 to 19) and the pellet fraction (fraction 20) are actin
rich (26, 28, 31). Similar to the enrichment seen in mammalian cells, we observed an
enrichment of PI(4,5)P2 in lipid rafts (fractions 9 to 14) (Fig. 2.1 A and B). However, the
actin-rich pellet fraction also possessed high levels of this phospholipid (Fig. 2.1 A and
B). Thus, there may be two pools of PI(4,5)P2 in E. histolytica, one pool in lipid rafts and
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another pool interacting directly with the actin cytoskeleton. However, we cannot rule out
the possibility that PI(4,5)P2 in rafts also interacts with the actin cytoskeleton in live cells.

Exposure to cholesterol increases levels of PI(4,5)P2 in the DRM. Previous studies in
mammalian cells have revealed that the level of membrane cholesterol influences the
localization of PI(4,5)P2 in the DRM (18). Therefore, we tested the effect of exposure to
cholesterol or to the cholesterol-sequestering agent MβCD on the localization and overall
levels of PI(4,5)P2 in E. histolytica trophozoites. On average, cells treated with 0.05
mg/ml cholesterol displayed a slight increase in PI(4,5)P2 levels in the lipid raft fractions
compared to control untreated cells; however, there was no difference in the level of
PI(4,5)P2 in the total DRM (Fig. 2.2 A to C). The most dramatic changes in the level of
PI(4,5)P2 in the total DRM were observed when the cells were exposed to 0.75 and 3
mg/ml cholesterol, with an approximately 60% increase (Fig. 2.2 A). In contrast, MβCD
caused a 56% decrease in the level of PI(4,5)P2 from that in the total DRM (Fig 2.2 A).
Furthermore, treatment with 0.75 and 3 mg/ml cholesterol increased the level of PI(4,5)P2
specifically in lipid rafts (Fig. 2.2 B and C). To determine if these changes were due to
overall increases or decreases in PI(4,5)P2, we also quantified total PI(4,5)P2 in whole
cells. We did not find a significant difference in the total cellular level of PI(4,5)P2 after
cholesterol or MβCD exposure (Fig. 2.2 D). Thus, PI(4,5)P2 may be moving between
membrane compartments in a cholesterol-dependent manner. However, we cannot rule
out the possibility that there is a rapid turnover of PI(4,5)P2, where continuous synthesis
and hydrolysis maintain a constant total level.
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Figure 2.1. PI(4,5)P2 compartmentalizes in lipid rafts and actin-rich pellet fractions. The
DRM was isolated from Entamoeba histolytica trophozoites and subjected to sucrose
gradient density fractionation. PI(4,5)P2 was extracted from these fractions, and lipid dot
blots were performed using antibodies specific to PI(4,5)P2. (A) A representative blot is
shown. Cells displayed PI(4,5)P2 enrichment in lipid raft fractions (fractions 9 to 14) and
in an actin-rich pellet fraction (fraction 20 P). (B) Semiquantitative scanning
densitometry was used to analyze the distribution of PI(4,5)P2 in membrane fractions,
correcting for the difference in the starting volume of each membrane fraction. The total
level of PI(4,5)P2 in the DRM was calculated, and the percentage of PI(4,5)P2 in each
fraction (± SD; n = 3) is presented.
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Figure 2.2. Exposure to cholesterol increases the levels of PI(4,5)P2 in the DRM and
specifically in lipid raft fractions. Trophozoites were serum starved and exposed to
cholesterol (0 to 3 mg/ml) or the cholesterol-depleting agent MβCD. Cells treated with no
cholesterol (0 mg/ml) served as the untreated control. (A to C) The DRM was isolated
and subjected to sucrose gradient density fractionation. PI(4,5)P2 was extracted from
these fractions, and lipid dot blots were performed using antibodies specific to PI(4,5)P2.
Levels of PI(4,5)P2 were analyzed by semiquantitative scanning densitometry. In all
cases, values were corrected for differences in starting volumes. (A) The total level of
PI(4,5)P2 in the DRM was calculated and reported as a percentage of that for the
untreated control. Cells treated with cholesterol (0.75 or 3 mg/ml) and MβCD displayed
an approximately 60% increase and 56% decrease in PI(4,5)P2 in the total DRM,
respectively, compared to the levels for the control (n ≥ 3) (*, P < 0.5; **, P < 0.01). (B)
A representative lipid dot blot of the sucrose gradient density fraction is shown. Cells
treated with cholesterol (0.75 and 3 mg/ml) displayed enhanced enrichment of PI(4,5)P2
in lipid rafts (fractions 9 to 14) compared to the control, while MβCD-treated cells
showed a decrease in PI(4,5)P2 from all fractions of the DRM. (C) The data represent the
percentage of PI(4,5)P2 in each fraction compared to the level of PI(4,5)P2 in the total
DRM of the untreated control cells (± SD; n ≥ 3). (D) Phosphoinositides were extracted
from whole-cell lysates, and PI(4,5)P2 levels were measured using dot blots with
antibodies specific to PI(4,5)P2. The level of PI(4,5)P2 for each treatment was quantified
by scanning densitometry and reported as a percentage of the level for the untreated
control. The total cellular PI(4,5)P2 level remained unchanged upon treatment with
cholesterol or MβCD. Data are the means ± SDs for ≥3 independent experiments.
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A GST-tagged PH probe reveals localization of PI(4,5)P2 to plasma membrane and
uroids. We have previously determined the subcellular localization of PI3P (35) and
PI(3,4,5)P3 (5) using a GST-tagged FYVE finger domain and a GST-tagged pleckstrin
homology (PH) domain of Bruton's tyrosine kinase (PHBtk), respectively. We used a
similar approach to determine the subcellular localization of PI(4,5)P2 using a
recombinant GST-tagged version of the PH domain from PLCD1 (PHPLCD1). This protein
domain has been shown to specifically bind PI(4,5)P2, and the GST-tagged chimera has
been used to study the localization of PI(4,5)P2 in mammalian cells (37).
Recombinant GST (control) and GST-PHPLCD1 were expressed in bacteria and
affinity purified. SDS-PAGE demonstrated that the proteins were 28 kDa and 48 kDa in
size, which are consistent with the predicted sizes of GST and GST-PHPLCD1, respectively
(Fig. 2.3 A). The authenticity of the GST tag was confirmed by Western blotting with
antibodies specific for GST (Fig. 2.3 B). To test the binding specificity of GST-PHPLCD1,
we employed a protein-lipid overlay assay as described previously (34, 37). The probe
bound to PI(4,5)P2 in a dose-dependent manner and did not display any significant
capacity for binding to other related phosphoinositides (Fig. 2.3 C). GST alone (control)
did not bind any of the phosphoinositides (data not shown). We also determined if the
probes bound nonspecifically to E. histolytica proteins. Whole-cell protein extract was
resolved by SDS-PAGE, electroblotted onto a nitrocellulose membrane, and decorated
with GST or GST-PHPLCD1. Neither GST nor GST-PHPLCD1 displayed binding to E.
histolytica proteins (Fig. 2.3 D). Together, these data suggest that the GST-PHPLCD1 probe
is highly specific for PI(4,5)P2 and does not cross-react with other cellular lipids or

60

proteins. Therefore, it could be utilized for subcellular localization of PI(4,5)P2.

Figure 2.3. The purified GST-PHPLCD1 biosensor binds with high affinity to PI(4,5)P2. (A)
SDS-PAGE and silver staining of GST and GST-PHPLCD1 fusion proteins after affinity
purification. The molecular mass markers are shown. (B) Western blot analysis of
purified GST and GST-PHPLCD1 using anti-GST antibody. (C) Serial dilutions (100 to 1.6
pmol) of the indicated phosphoinositides were spotted onto a nitrocellulose membrane
and incubated with 0.2 µg/ml of GST-PHPLCD1. Binding of the protein was detected with
anti-GST antibodies. The probe exhibited binding specificity to PI(4,5)P2 alone. (D)
Whole-trophozoite extracts (5 × 105 and 1 × 105 cells) were resolved by SDS-PAGE and
electroblotted onto a Hybond-C nitrocellulose membrane. Individual lanes of lysate were
decorated with GST (i), GST-PHPLCD1 (ii), or anti-actin antibody (positive control for
protein transfer) (iii). (ii) As an additional control for binding of the GST-PHPLCD1 probe,
the membrane was washed after the protein transfer and serial dilutions of PI(4,5)P2 were
spotted on the same membrane and incubated with GST-PHPLCD1. Binding of the probes
was detected with anti-GST antibodies. Neither GST nor GST-PHPLCD1 probe bound to
the whole-cell protein extract, further supporting the specificity of the probe.

E. histolytica trophozoites were fixed, permeabilized, and stained with GST or
GST-PHPLCD1, followed by staining with a fluorescence-labeled anti-GST antibody.
Confocal microscopy revealed that cells stained with control GST exhibited minimal
fluorescence (Fig. 2.4 A and D). In contrast, the GST-PHPLCD1 probe uniformly decorated
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the plasma membrane, giving most cells a ring-like appearance (Fig. 2.4 B and E). This
was not surprising, as PI(4,5)P2 is known to account for 1% of plasma membrane
phospholipids and >99% of all doubly phosphorylated phospholipids and is maintained at
a high steady-state level in mammalian cells (reviewed in references 17, 20, and 38).
Interestingly, in some cells, PI(4,5)P2 was also enriched on one side of the cell, opposite
apparent forming pseudopods (Fig. 2.4 C and F).

Figure 2.4. The PI(4,5)P2 biosensor GST-PHPLCD1 decorates the plasma membrane of E.
histolytica. Trophozoites were stained with GST or GST-PHPLCD1 and fluorescent antiGST antibody, and immunofluorescence confocal microscopy was performed. (A) Cells
stained with the control, GST, exhibited minimal staining. (B) GST-PHPLCD1 uniformly
decorated the plasma membrane of the trophozoites, giving the cells a ring-like
appearance. (C) In some instances, there was an enrichment of GST-PHPLCD1staining on
one edge of the cell (arrow), opposite an apparent pseudopod (arrowhead). (D to F) The
differential interference contrast (DIC) images corresponding to the images in panels A to
C, respectively, are shown.
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Studies in other systems (18) and our biochemical analysis (Fig. 2.2 A to C)
indicated that cholesterol levels impact the localization of PI(4,5)P2 in the DRM.
Therefore, we wanted to determine the subcellular localization of PI(4,5)P2 in whole cells
after exposure to cholesterol or after cholesterol depletion. Interestingly, there was an
increase in the number of cells displaying PI(4,5)P2 localization at one edge upon
cholesterol treatment (Fig. 2.5 B and E) compared to the number for the untreated control
(Fig. 2.5 A and D). Image analysis revealed that there was a 3.4-fold increase in the
number of cells displaying this morphology after cholesterol treatment compared to the
number of control cells (Fig. 2.5 G). In contrast, cholesterol depletion with MβCD
disrupted the localization of PI(4,5)P2 at the plasma membrane, in that it was observed in
the interior of the cell (Fig. 2.5 C and F). This suggested a requirement of cholesterol
richness for proper localization of PI(4,5)P2 to the plasma membrane.
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Figure 2.5. Treatment with cholesterol enhances the number of cells displaying PI(4,5)P2
enrichment at the edge opposite the forming pseudopod. Trophozoites were serum
starved and exposed to either 0 mg/ml cholesterol (control), 3 mg/ml cholesterol, or the
lipid raft-disrupting agent MβCD. Cells were stained with GST-PHPLCD1 and fluorescent
anti-GST antibody, and immunofluorescence confocal microscopy was performed. (A
and B) Cholesterol-treated cells displayed an increased PI(4,5)P2 localization on one edge
of the cell compared to untreated control cells. (C) In MβCD-treated cells, PI(4,5)P2
staining was no longer confined to the plasma membrane. (D to F) The DIC images
corresponding to the images in panels A to C, respectively, are shown. (G) The
percentage of apparently polarized cells in control cells or after cholesterol treatment was
quantified by visually scoring cells at ×20 magnification. There was a 3.4-fold increase in
the number of cells displaying PI(4,5)P2 localization on one edge after cholesterol
treatment compared to the number for untreated control cells. Data are the means ± SDs
of 3 independent experiments (***, P < 0.001).

Cholesterol treatment enhances motility. In other systems, PI(4,5)P2 plays an essential
role in cell motility. Since PI(4,5)P2 became asymmetrically distributed after exposure to
cholesterol (Fig. 2.5 B and E) and since asymmetry is a hallmark of motile cells, we
hypothesized that exposure to cholesterol was enhancing motility. To test this, we utilized
a previously published under-agar motility assay (36) to determine the effect of
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cholesterol exposure on cell movement. Upon exposure to cholesterol, the ability of the
trophozoites to move out of the wells increased significantly in a dose-dependent fashion
(Fig. 2.6 A). After exposure to cholesterol, not only did cells traverse longer distances but
also there was an apparent increase in the number of motile cells (Fig. 2.6 B and C). This
suggests a possible role for cholesterol in mediating motility in E. histolytica.

Figure 2.6. Exposure to cholesterol enhances motility in E. histolytica cells. E. histolytica
trophozoites were serum starved and exposed to 0 to 3 mg/ml cholesterol. A motility
assay was performed, and images were captured using confocal microscopy. The distance
migrated by trophozoites was measured. (A) Trophozoites exhibited a dose-dependent
and statistically significant increase in motility after exposure to cholesterol (**, P <
0.01; ***, P < 0.001). The data represent the means ± SDs from ≥3 independent
experiments. (B and C) Cholesterol treatment also increased the number of motile cells
compared to the number of untreated control cells entering the agar. Representative ×10
magnification fields of control cells and cells treated with 3 mg/ml cholesterol are shown.
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PI(4,5)P2 localizes to uroids in ConA-capped E. histolytica cells. In apparently polarized
cells, PI(4,5)P2 appeared to be enriched on one edge opposite that of the forming
pseudopods. This could represent localization of PI(4,5)P2 to the trailing edge (uroid).
Therefore, we employed a polyvalent ligand, ConA, which is known to interact with and
cap cell surface receptors at the trailing edge of the trophozoites (39). Thus, labeled
ConA serves as a uroid marker. PI(4,5)P2 colocalized with fluorescent ConA in uroids
(Fig. 2.7 A to D) and with patches of ConA in trophozoites in which capping was
initiated but was not complete (data not shown).

Figure 2.7. Fluorescence confocal microscopy of ConA-capped E. histolytica reveals
localization of PI(4,5)P2 to uroids. (A to D) Trophozoites were incubated with fluorescein
isothiocyanate-ConA (green) for 1 h on ice, followed by incubation at 37°C for 15 min to
initiate uroid formation. Cells were fixed and stained with GST-PHPLCD1 and anti-GST
antibody (red).
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Lipid rafts localize to uroids. Since our biochemical analysis demonstrated that lipid rafts
were enriched in PI(4,5)P2 and since microscopy revealed that PI(4,5)P2 localized to
uroids, we wanted to determine if, like in mammalian cells (40), the uroids of E.
histolytica were enriched in lipid rafts. Therefore, we employed a lipid raft stain, DiIC16,
on fixed E. histolytica trophozoites as previously described (27). Cells with no apparent
pseudopod formation (nonpolarized) displayed a uniform plasma membrane raft staining
(Fig. 2.8 A and B), whereas apparently polarized cells also showed an enrichment of raft
staining at one edge opposite the forming pseudopod (Fig. 2.8 C and D). Colocalization
of DiIC16 with ConA revealed that the uroids were indeed enriched in lipid rafts (Fig. 2.8
E to H). Similar to the results seen for PI(4,5)P2 staining, trophozoites with incomplete
uroid formation exhibited DiIC16 staining that colocalized with lateral patches of ConA
(data not shown).
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Figure 2.8. Fluorescence confocal microscopy of ConA-capped E. histolytica reveals
localization of lipid rafts to uroids. The lipid raft localizes to uroids in E. histolytica. (A
to D) Trophozoites were fixed and stained with the lipid raft marker DiIC16.
Nonpolarized cells displayed uniform plasma membrane raft staining, while apparent
polarized cells exhibited an enriched raft staining on one edge (arrowheads) opposite the
pseudopod (arrows). (E to H) E. histolytica trophozoites were incubated with fluorescein
isothiocyanate-ConA (green) for 1 h on ice, followed by incubation at 37°C for 15 min to
initiate uroid formation. Cells were fixed and stained with the raft marker DiIC16 (red).
There was a colocalization of ConA and DiIC16 staining at the uroid of E. histolytica,
further supporting the finding that lipid rafts are enriched at uroids in polarized cells.
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Cholesterol treatment enhances intracellular Ca2+ levels in E. histolytica. In other
systems, PLCD1 hydrolyzes PI(4,5)P2 into IP3 and DAG, which facilitates Ca2+ signaling
(13, 41). Since PLCD1 also localizes to rafts (42), it is reasonable to hypothesize that the
accumulation of PI(4,5)P2 in rafts after cholesterol treatment might lead to an increase in
intracellular Ca2+. Therefore, we measured intracellular Ca2+ levels after cholesterol
treatment using a previously published protocol (31). Several studies have demonstrated
that bona fide ligands of E. histolytica, such as collagen and fibronectin themselves,
induce signaling leading to increased intracellular Ca2+ (31, 43). Therefore, to test the
effect of cholesterol alone on intracellular Ca2+ levels, we utilized uncoated 96-well
plates for our studies. After 1 h of pretreatment with cholesterol, we observed a
significant dose-dependent increase in Ca2+ (Fig. 2.9 A). Since signaling events take
place immediately following stimulation, we also tested a shorter time of exposure to
cholesterol. After 15 min of pretreatment with 0.75 and 3 mg/ml cholesterol, we observed
similar increases in Ca2+, of which some were statistically significant (Fig. 2.9 B).
Together, these data indicate the possibility of a cholesterol-dependent, PI(4,5)P2mediated rise in intracellular Ca2+ levels.
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Figure 2.9. Exposure to cholesterol increases intracellular Ca2+ levels in E. histolytica.
Trophozoites were serum starved and exposed to cholesterol at concentrations of 0
(control) to 3 mg/ml for either 60 or 15 min. Intracellular Ca2+ levels were measured after
treatment over a 35-min time interval. Intracellular Ca2+ levels at the 35-min time point
for the untreated control cells were arbitrarily set equal to 100%, and the values at the
other time points were reported as a percentage of this final value. The data are the means
± SDs for ≥3 independent experiments. (A) Sixty minutes of pretreatment with 0.75 or 3
mg/ml cholesterol resulted in a significant increase in the intracellular Ca2+ level
compared to that for untreated controls (*, P < 0.5; **, P < 0.01; ***, P < 0.001). (B)
Similarly, an increase in intracellular Ca2+ levels was observed with a 15-min cholesterol
pretreatment (*, P < 0.5).

DISCUSSION
This study represents the first analysis of the submembrane localization of
PI(4,5)P2 in E. histolytica. Biochemical analyses showed that PI(4,5)P2 is
compartmentalized in lipid raft and actin-rich pellet fractions of the DRM. Microscopy
demonstrated that PI(4,5)P2 uniformly decorated the plasma membrane in a majority of
the cells but also colocalized with lipid rafts at the uroids in polarized cells. The
connection between PI(4,5)P2 and rafts in E. histolytica was supported by our
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observations that cholesterol treatment increased the level of PI(4,5)P2 in the DRM, lipid
rafts, and raft-rich uroids and that MβCD depleted the DRM and plasma membrane of
PI(4,5)P2. Finally, treatment with cholesterol resulted in an increase in intracellular Ca2+
[a downstream effector of PI(4,5)P2] and a concomitant increase in motility. Therefore, in
E. histolytica, PI(4,5)P2 may signal from rafts and cholesterol may play a role in
triggering PI(4,5)P2-dependent signaling.
Various studies have supported the existence of different cellular pools of
PI(4,5)P2 to explain the complex roles of PI(4,5)P2 in cells (reviewed in reference 38). In
E. histolytica, we observed compartmentalization of PI(4,5)P2 in lipid rafts as well as in
the actin-rich pellet fraction at steady state. We also showed that exposure to cholesterol
resulted in enrichment of PI(4,5)P2 in the DRM and, specifically, in lipid rafts without an
increase in the total cellular level of PI(4,5)P2. One explanation for this is that PI(4,5)P2
translocates between membrane subcompartments in a cholesterol-dependent fashion.
The parasite likely encounters different extracellular cholesterol levels depending on the
location in the human host (e.g., liver versus intestine). Therefore, simple translocation of
PI(4,5)P2 between membrane domains would represent a rapid way to regulate lipid
signaling throughout infection. Ca2+ is a downstream effector of PI(4,5)P2 and
accumulates upon hydrolysis of PI(4,5)P2 to IP3 and DAG. Since we also observed an
increase in the intracellular Ca2+ level upon cholesterol treatment, it is also possible that
there is rapid hydrolysis and synthesis of PI(4,5)P2 in rafts, which would maintain the
apparent constant total cellular level of this lipid. In other systems, in addition to PLCD1
(42), enzymes that synthesize PI(4,5)P2, such as phosphatidylinositol-4-phosphate-5-
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kinase (PIP5K), are also recruited to rafts upon stimulation (44, 45). Thus, it is
conceivable that rapid turnover of PI(4,5)P2 could occur in rafts.
We cannot rule out the possibility that it is actually the rise in intracellular Ca2+
that induces segregation of PI(4,5)P2 into rafts. Using an in vitro lipid monolayer system,
Levental et al. (46) showed that the lateral organization of PI(4,5)P2 is sensitive to small
changes in Ca2+ concentration. However, it is not known if Ca2+ can influence the
submembrane distribution of PI(4,5)P2 in vivo. Regardless of whether there is a Ca2+dependent step, the outcome of exposure of trophozoites to cholesterol is enrichment of
PI(4,5)P2 in lipid rafts. This provides significant insight into signaling in this parasite.
In the present study, we demonstrated that PI(4,5)P2 uniformly decorates the plasma
membrane of this parasite. We also showed that in polarized cells, both lipid rafts and the
constituent signaling lipid, PI(4,5)P2, localize to the uroids. In mammalian cells, there is
increasing evidence that lipid rafts play a vital role in delivering signaling molecules to
uroids during cell migration. For example, Millán et al. (40) showed that the uroids of
polarized T lymphocytes are enriched in cholesterol and disruption of rafts leads to loss
of uroids and subsequent inhibition of cell migration. Furthermore, segregation of
membrane proteins to uroids and pseudopods is inhibited by disruption of lipid rafts in T
lymphocytes (40, 47) and neutrophils (21). Another study of polarized neutrophils
revealed that DiIC16-stained raft fractions progress from a uniform distribution to discrete
patches that coalesce at uroids to form caps (48). Furthermore, cap formation in these
cells relies on the interaction of transmembrane proteins of the DRM with both the lipids
of the DRM and the proteins of the actomyosin cytoskeleton (48). Since we observed the
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localization of lipid rafts and PI(4,5)P2 in uroids and in ConA-positive, laterally localized
membrane patches, it is possible that a similar lipid raft-mediated delivery of PI(4,5)P2 to
uroids occurs in E. histolytica. Another mechanism by which PI(4,5)P2 could become
enriched in uroids is by local synthesis. A number of reports in other systems have shown
that key PI(4,5)P2-synthesizing enzymes also localize to uroids (49–52). However,
whether these enzymes localize to uroids of E. histolytica remains to be determined.
PI(4,5)P2 can function as a second messenger and bind various actin-binding proteins. A
proteomic analysis of E. histolytica uroids identified the presence of actin-binding
proteins that have been reported to interact with PI(4,5)P2 in other eukaryotic cells,
including the spectrin-family proteins (e.g., filamin 2, an actinin-like protein) and a novel
protein, filopodin (53). In other systems, PI(4,5)P2 has been shown to regulate actin
cytoskeleton by binding and modulating filamin (54) and α-actinin (55). Filopodin is an
ezrin-radixin-moesin (ERM) domain-containing protein. Members of the ERM family
bind PI(4,5)P2 and are known to regulate uroid formation in T cells (56). Thus, PI(4,5)P2
may serve as a bridge at the uroid, connecting the cytoskeleton to the plasma membrane
through various actin-binding proteins.
PI(4,5)P2 can also generate a variety of secondary messenger molecules. For
instance, at the leading edge of Dictyostelium discoideum cells, PI(4,5)P2 is converted to
PI(3,4,5)P3 by PI3K; PI(3,4,5)P3 binds to and recruits several proteins to promote
pseudopod formation (reviewed in reference 52). Likewise, PI(3,4,5)P3 localizes to
pseudopods of motile E. histolytica (5). At the trailing edge of mammalian cells,
hydrolysis of PI(4,5)P2 to DAG, which activates PKC, is essential for T cell chemotaxis
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(57). IP3, another product of PI(4,5)P2 hydrolysis, stimulates an increase in intracellular
Ca2+ levels, and increases in Ca2+ correlate with enhanced motility in neutrophils (58,
59). Ca2+ is a potent stimulator of motility through activation of myosin light-chain
kinase (MLCK), leading to an increase in myosin II-based contractility at the uroid (60).
In the current study, an increase in intracellular Ca2+ was accompanied by a robust
augmentation of motility after exposure to cholesterol. Thus, a similarly potent PI(4,5)P2
to Ca2+ to MLCK system may exist in this pathogen. In support of this, myosin II is
found to localize to the uroids of E. histolytica (2).
On average, we observed a modest increase in PI(4,5)P2 levels in rafts after
treatment with 0.05 mg/ml cholesterol, but there was no difference in the total PI(4,5)P2
levels in the DRM. One explanation for observing a statistically significant increase in
motility after treatment with the same concentration of cholesterol could be that motility
is very sensitive to the submembrane position of PI(4,5)P2 and even small increases in
PI(4,5)P2 in rafts can cause enhanced cell movement. Our observation that an increase in
PI(4,5)P2 in rafts and uroids is accompanied by increases in intracellular Ca2+ and
motility is suggestive of raft-mediated signaling from PI(4,5)P2. However, it remains to
be seen if the effect of PI(4,5)P2 on motility after exposure to cholesterol is direct or
indirect. One way to test this would be to generate E. histolytica cells with reduced levels
of enzymes that are responsible for PI(4,5)P2 synthesis (e.g., by knockdown of PIP5K). In
E. histolytica, these enzymes have not yet been definitively identified. Genome data
suggest the existence of a putative E. histolytica PIP5K gene (GI:67481998), and a
BLASTP analysis of the translated protein sequence revealed a 41% identity to human
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phosphatidylinositol-4-phosphate-5-kinase type 1β. However, it remains to be seen if this
an authentic PI(4,5)P2-synthesizing enzyme.
Cholesterol is a major constituent of the eukaryotic plasma membrane (61). Aley
et al. (62) demonstrated that E. histolytica possesses a high plasma membrane content of
cholesterol, with a cholesterol/phospholipid molar ratio of 0.87. There are intriguing
correlations between E. histolytica virulence and cholesterol. For example, cholesterol
has been shown to enhance virulence functions in E. histolytica, including adhesion (27,
28), expression of ConA binding sites on the cell surface (63), and hemolytic and
erythrophagocytic activity (64). Several studies have demonstrated that it is possible to
revive the virulence of avirulent E. histolytica strains by supplying medium with
cholesterol (65, 66) or by repeated passage through liver, which is a major site of
cholesterol synthesis (67). Finally, long-term culture of E. histolytica in medium
supplemented with liposomes carrying phosphatidylcholine and cholesterol can preserve
virulence (63). Our study is the first to show that cholesterol impacts the submembrane
and subcellular localization of PI(4,5)P2 in E. histolytica and could be key to unraveling
the molecular mechanism by which cholesterol regulates virulence.
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ABSTRACT
Entamoeba histolytica is an intestinal protozoan parasite that causes amoebic
dysentery and liver abscess. E. histolytica relies on cell motility, phagocytosis, host cell
adhesion, cell killing, and proteolysis of extracellular matrix for virulence and
propagation. In eukaryotic cells, these processes are mediated, in part, by
phosphatidylinositol 3-kinase (PI3K) signaling. Thus, PI3K may be critical for virulence.
In this study, we utilized a functional genomics approach to identify genes that may
operate in the PI3K pathway in E. histolytica. We treated a population of trophozoites,
which were transfected with E. histolytica over-expression cDNA library, with a nearlethal dose of the PI3K inhibitor, wortmannin. This screen was based on the rationale that
survivors may be over-expressing gene products that directly or indirectly function in the
PI3K pathway in E. histolytica. We then identified the over-expressed genes in survivors.
We isolated a cDNA encoding a Rap GTPases that was previously shown to participate in
the PI3K pathway. This supports the validity of our approach. Genes encoding a
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coactosin-like protein, EhCoactosin, and a serine-rich E. histolytica protein (SREHP)
were also identified in our screen. We utilized an independent genetic test to strengthen
the connection between SREHP or EhCoactosin, and PI3K signaling. The assignment of
these proteins as putative partners in PI3K signaling is novel. To our knowledge, this is
the first forward genetics screen adapted to reveal genes participating in PI3K pathway in
this pathogen.

INTRODUCTION
Entamoeba histolytica is an enteric parasitic protozoan that is known to cause
amoebiasis in humans. Infection with E. histolytica is responsible for an estimated
100,000 deaths each year (1). It is mainly prevalent in developing countries that cannot
prevent its fecal-oral spread. E. histolytica enters the human host upon ingestion of
environmentally stable cysts in contaminated water or food. After passing through the
stomach, excystation leads to the release of trophozoites, which then migrate to the bowel
for colonization. In 10% of the infected individuals, infection can progress from a noninvasive stage to an invasive stage (2), which is characterized by adhesion to and
destruction of colonic epithelium. From here, the parasites enter the circulatory system
and translocate to other organs. The most common site of extraintestinal infection is the
liver, characterized by the formation of amebic liver abscess (ALA).
E. histolytica relies on cell motility, phagocytosis, host cell adhesion, killing, and
proteolysis of extracellular matrix for virulence (3). In eukaryotic cells, these processes
are mediated, in part, by phosphatidylinositol 3-kinase (PI3K) signaling (4). PI3Ks
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phosphorylate phosphatidylinositol (PI) and its derivatives to generate signaling lipids
such as phosphatidylinositol 3-phosphate (PI3P), phosphatidylinositol 3,4-bisphosphate
(PI(3,4)P2), phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) and phosphatidylinositol
3,4,5-trisphosphate (PI(3,4,5)P3) (reviewed in (5)). These lipids can further propagate a
signal by interacting with proteins harboring specific domains such as FYVE finger
domains, which bind PI3P, and pleckstrin homology (PH) domains, which bind
PI(3,4,5)P3 and PI(3,4)P2 (reviewed in (6)). The activity of PI3K can be countered by the
action of phosphatases such as phosphatase and tensin homolog (PTEN), which
dephosphorylate phosophoinositides (reviewed in (7)).
In E. histolytica, the products of PI3Ks have been studied using GST- and GFPtagged versions of FYVE and PH domains (8-10). These studies have shown that PI3P
localizes to E. histolytica phagosomes (8, 9) and PI(3,4,5)P3 localizes to both pseudopods
and phagosomes (10). Small molecule inhibitors of PI3K, such as LY294002 and
wortmannin, have also been employed to study the role of this enzyme and its products in
E. histolytica pathogenesis.
Treatment of E. histolytica trophozoites with wortmannin inhibits directional cell
polarization (11), motility, actin cytoskeletal rearrangements, proteolytic activity and the
development of ALA in an animal model of disease (12). Exposure to either LY294002
(13) or wortmannin inhibits pinocytosis of a fluorescent fluid phase marker, FITCdextran (14), and disrupts phagocytosis (8, 10, 14) and adhesion to host cells in a dosedependent manner (8).
Several unique aspects of PI3K activity in E. histolytica make it worthy of study.
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First, expression of PI3K is higher in virulent E. histolytica as compared to nonvirulent E.
dispar (15). Second, though not much is known about encystation in E. histolytica,
wortmannin inhibits encystation in a related pathogen, E. invadens (16). Therefore, it is
possible that E. histolytica encystation also requires PI3K activity. Third, as compared to
mammalian cells, E. histolytica has unusually high levels of PI(3,4,5)P3 at the plasma
membrane (10). Fourth, unlike mammalian cells (17), serum withdrawal does not affect
the steady-state PI(3,4,5)P3 levels in E. histolytica (10). Finally, the products of PI3K,
PI3P and PI(3,4,5)P3, localize to early forming or newly sealed phagosomes (8-10). In
contrast, localization of PI3P to phagosomes in mammalian cell is observed only after
their closure (18). Thus, understanding the unique role of phosphoinositides and PI3K
signaling in E. histolytica may provide insight into infection.
In other systems, genome-wide over-expression has been used to identify targets of
small molecule drugs. For example, Butcher et al. (19) used over-expression to identify
genes regulating rapamycin sensitivity and hence, TOR kinase signaling. Similarly,
genome-wide over- expression was used to define targets of a kinase inhibitor,
phenylaminopyrimidine (20), and two antifungal drugs, tunicamycin and soraphen (21).
Sequencing and annotation of the E. histolytica genome (22, 23) have enabled the
development of whole genomic approaches to assign functions to genes. However, to
date, the only forward genetics approach that has been applied to E. histolytica is a recent
over-expression screen that identified genes that negatively regulate phagocytosis (24).
In the current study, we have adapted an over-expression-based chemical genomic
approach (25) to uncover genes that may directly or indirectly participate in PI3K
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signaling. Specifically, we applied a near-lethal dose of wortmannin to a population of
cells that had been transfected with an E. histolytica cDNA library to select for cells that
were less sensitive to the drug. We then identified the genes that were over-expressed in
the survivors. We hypothesized that cells in which wortmannin toxicity was genetically
suppressed were over-expressing genes whose products directly or indirectly play a role
in PI3K signaling. We uncovered a Rap GTPase that has been shown to participate in
PI3K signaling in other systems (26, 27). We also identified several genes not previously
known to be partners in PI3K signaling. To our knowledge, this is first genetic screen in
E. histolytica to identify genes that affect wortmannin sensitivity, and thus, PI3K
signaling.

MATERIALS AND METHODS
Strains and culture conditions. Entamoeba histolytica trophozoites (strain HM-1:1MSS)
were cultured axenically in TYI-S-33 medium (29) in 15 ml glass screw-cap tubes at
37°C. The generation of an E. histolytica cell line conditionally over-expressing a GFPtagged pleckstrin homology (PH) domain from mammalian Bruton’s tyrosine kinase
(GFP-PHBtk) is described elsewhere (10). This transgenic cell line was maintained in
TYI-S-33 medium supplemented with 6 µg/ml G418 and 15 µg/ml hygromycin. GFPPHBtk expression was induced by the addition of 5 µg/ml tetracycline to the culture
medium 24 h prior to performing assays. The generation of a population of E. histolytica
cells transfected with a cDNA library in the E.histolytica expression vector, pAH-DEST,
is described elsewhere (24). The population of over- expressing cells was maintained by
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the addition of 23 µg/ml hygromycin to the medium. E. histolytica trophozoites were
transfected with the expression plasmids encoding SREHP or EhCoactosin using standard
transfection protocols (10, 30). The 2nd generation SREHP- and EhCoactosin-overexpressors were maintained in a medium supplemented with 23 µg/ml hygromycin and
the drug concentration was increased to 46 µg/ml for 1 week prior to conducting
experiments.
Measurement of wortmannin toxicity and chemical genomics screen. Log-phase
trophozoites (2 × 104 cells) were seeded into 13 ml of TYI-S-33 medium containing a
range of concentrations of wortmannin or its diluent, dimethyl sulfoxide (DMSO), and
grown for 3 days in 15 ml glass screw-cap tubes at 37°C. Fresh TYI-S-33 medium
containing the drug or the diluent was supplied to the cells every 24 h over the course of
treatment. Cell viability was measured by microscopy with Trypan Blue exclusion. A
near-lethal concentration of wortmannin (2 mM) was applied to the library of overexpressing trophozoites for 3 days with a media change every 24 h.
Isolation of episomes from survivors and sequencing. Total DNA was isolated from the
population of cells that survived wortmannin selection or from the parental population of
cells not exposed to wortmannin (control) using the Wizard Genomic DNA Purification
Kit (Promega, Madison WI). The isolated DNA was transformed into Escherichia coli
(XL10 GOLD, Stratagene, LaJolla, CA) by standard transformation protocols. The
resulting ampicillin-resistant bacterial colonies were randomly chosen from each
condition (unselected control or wortmannin-selection), transferred to the wells of 96well plates containing LB medium supplemented with ampicillin (100 µg/ml) and
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glycerol (50% vol/vol) and stored at -80°C. Frozen samples were transferred to to
Arizona State University BioDesign Institute (Tempe, AZ) for automated plasmid
isolation and sequencing.
Analysis of expression by quantitative real-time PCR. The 2nd generation transgenic cell
lines expressing SREHP and EhCoactosin were grown to mid log phase (3 × 105
cells/ml). Total RNA was isolated with Trizol® Reagent (Invitrogen, Carlsbad, CA), and
2 µg of RNA was treated with DNAase I for 30 min at 37°C. cDNA was synthesized with
oligo-dT and Superscript III reverse transcriptase (Invitrogen) at 50°C for 2 h.
Expression of SREHP or EhCoactosin was measured by quantitative real-time PCR
(qPCR) using the RT2 SYBR Green Fluor qPCR Mastermix (SABiosciences, Frederick,
MD)

and

the

appropriate

primers

GCTGCATCAAGTCCATTCATTG-

for

SREHP

3’;

(forward

reverse

primer

primer

GATAGAAATATTTATCCCAACTAAAGAC-3’) and EhCoactosin (forward
5’-TTAGTGAAGTTGCTGGCCCAGTTG-3’;

reverse

primer

5’5’-

primer

5’

-

GCATCTTCCTTAAGGGCAGCTTTG-3’). Normalization of the levels of cDNA was
carried out by comparing expression to that of a housekeeping gene, the small subunit
ribosomal RNA (ssRNA)

(Accession No. X61116)

AGGCGCGTAAATTACCCACTTTCG-3’; reverse

(31) (forward primer 5’primer

5’-

CACCAGACTTGCCCTCCAATTGAT-3’). Normalization ratios were calculated using
the Pfaffl method (32).
Cycloheximide-sensitivity assay. A cycloheximide-sensitivity assay was employed as
described (24). Briefly, trophozoites (3 × 104 cells) were seeded into 13 ml of TYI-S-33
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medium
supplemented with 100 nM cycloheximide or an equivalent PBS (diluent control) and
incubated at 37°C for 48 h. Cell viability was assessed by microscopy with Trypan Blue
exclusion.
Whole cell lipid extraction and PI(3,4,5)P3 dot blots. Total lipid was extracted from wildtype and GFP-PHBtk-expressing trophozoites according to the methods of Gray et al. (33).
Briefly, 1 × 106 cells were washed twice with phosphate-buffered saline (PBS). Lipids
were precipitated with 5 ml of 0.5 M trichloroacetic acid (TCA) and centrifuged at 500 ×
g for 5 min at 4°C. The pellets were washed with 3 ml of 5% (wt/vol) TCA-1 mM EDTA
and centrifuged at 500 × g for 5 min. To facilitate neutral lipid extraction, 3 ml of
methanol-chloroform (2:1) was added to the pellets, and the mixture was vortexed 3
times over a period of 10 min at room temperature. The extracted lipids were centrifuged
at 500 × g for 5 min at 4°C. To facilitate acidic lipid extraction, 2.25 ml methanolchloroform-12.1 N HCl (80:40:1) was added, and the mixture was vortexed 4 times over
15 min at room temperature and centrifuged at 500 × g. The resulting supernatant was
subjected to a phase split by the addition of 750 µl chloroform and 1.35 ml 0.1N HCl.
The solution was centrifuged at 500 × g for 5 min at 4°C. After centrifugation, the
organic phase was collected and vacuum dried and the pellets were used for lipid dot blot
analysis.
Lipids were spotted onto hybond-C nitrocellulose membrane. The membrane was
blocked in 1.5% (w/v) fatty acid-free bovine serum albumin (BSA) at room temperature
for 1 h and probed with mouse anti-PI(3,4,5)P3 antibody (1:1,000 dilution) (Echelon
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Biosciences, Salt Lake City, UT) followed by incubation with secondary antibody,
peroxidase-conjugated

goat

anti-mouse

IgG

(1:2,000

dilution)

(Cappel;

ICN

Pharmaceuticals, Costa Mesa, CA). Immunoblots were visualized using the enhanced
chemiluminescence Western blotting detection system (Pierce Biotechnology, Rockford,
IL) according to the manufacturer's instructions. Semi-quantitative densitometric analyses
of immunoblots were performed using ImageJ software (Version 1.42q; U.S. National
Institutes of Health, Bethesda, MD).
Measurement of motility. Motility assays were carried out according to the methods of
Zaki et al. (34). Briefly, 8 ml of complete TYI-S-33 medium, supplemented with 0.75%
(wt/vol) agarose, was poured into 60 mm petri dishes and allowed to solidify at room
temperature. A trough (2 × 30 mm) was cut into the solidified medium to serve as the
motility chamber. Wild- type trophozoites or EhCoactosin over-expressors were
incubated in serum-free media for 1 h at 37°C. Following this incubation, 5 × 105 cells
were placed in the trough of the motility chamber. A coverslip (22 × 40 mm) was placed
over the trough, and the plate was incubated at 37°C for 3 h in 5% CO2. Images were
captured using a LSM510 confocal microscope (Carl Zeiss MicroImaging, Thornwood,
NY). The migration distance was measured using Zeiss LSM510 image analysis
software.
Statistical analyses. All values are given as a mean ± standard deviation (S.D.) of at least
3 trials. To compare means, statistical analyses were performed using GraphPad Instat®
V.3 with an unpaired t-test, Welch corrected (two-tail P-value) or with one-way analysis
of variance (ANOVA) and a Tukey-Kramer multiple comparison test. In all cases, P
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values less than 0.001 (***) were considered highly statistically significant, while P
values less than 0.01 (**) or 0.05 (*) were considered statistically significant.
In silico analyses. Structural and functional amino acid residues and domains in the
EhCoactosin protein were identified using ExPASy ScanProsite (35). Cartoon renderings
of the EhCoactosin protein was generated using the MyDomains-Image Creator in
ExPASy PROSITE. Clustal W algorithm was used for comparisons of coactosin protein
sequences (MacVector 9.0; Cary, NC).

RESULTS
Development of chemical genomic screen to enrich for mutants hyposensitive to
wortmannin. Wortmannin is a cell-permeant, small molecule metabolite isolated from the
fungus Talaromyces wortmanni (36). In mammalian cells, wortmannin can irreversibly
inhibit PI3K at low nanomolar concentrations (reviewed in (7)). To evaluate wortmannin
toxicity in E. histolytica, we exposed trophozoites to a range of concentration of
wortmannin over 3 days. In E. histolytica, PI3P and PI(3,4,5)P3 staining were eliminated
by 60 nM (8) and 500 nM (10) wortmannin, respectively. Since we were interested in
completely disabling PI3K, we tested 500 nM (data not shown) up to 4 mM wortmannin.
To ensure the presence of active inhibitor, the spent medium was exchanged with fresh
wortmannin-containing medium daily. The viability of the trophozoites was assessed and
reported as a percent of untreated control cells. Near 100% death of trophozoites
population was achieved with 2 mM (~1.5% viable after 3 days), 3 mM (~0.9% viable
after 3 days), and 4 mM (~0.5% viable after 3 days) of wortmannin (Fig. 1). Further,
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there was no statistically significant difference when 2 mM wortmannin toxicity was
compared to that of higher doses. Cell viability was not significantly affected by the
diluent, DMSO (Fig. 3.1). This suggests that cell death was specific to the presence of
wortmannin. To minimize off-targets effects of wortmannin (reviewed in (7)), and to
maximize the chances of identifying genes authentically connected to PI3K signaling, 2
mM wortmannin treatment was chosen for the chemical genomics screen.

Figure 3.1. Wortmannin is toxic to E. histolytica. Trophozoites (2 X 104 cells) were
exposed to a range of concentrations of wortmannin or its diluent, dimethyl sulfoxide
(DMSO), or an equivalent volume of media (control) and grown for 3 days. Cell viability
was assessed and expressed as a percent of untreated control cells. The data represent the
mean ±S.D of 3 trials (***P<0.001). Treatment with 2 mM or higher concentrations of
wortmannin resulted in the death of nearly 100% of the cells.
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Screening with wortmannin identifies genes that may function in PI3K signaling. E.
histolytica cells were transfected with a cDNA over-expression library constructed in the
episomal, constitutive expression vector, pAH-DEST (37) as described (24). The
transgenic population of cells was exposed to 2 mM wortmannin over a three day period
as described above. The surviving cells were allowed to recover for a 48 h period.
Episomes from the surviving population were purified and amplified in E. coli. The
cDNAs were identified by sequencing. As a control, episomes were also isolated and
sequenced from the transgenic population of cells that was not subjected to this selection.
Table. 1 shows the identity and frequency of cDNAs isolated from trophozoites that
survived selection as compared to those recovered randomly from a population of overexpressing cells not subjected to selection.
The cDNAs most highly enriched by selection with wortmannin encoded an actinbinding protein with an actin depolymerization factor homology (ADF-H) domain
(EhCoactosin; GI:183233207), an ehapt2 retrotransposon (GI:25989677), the 40s
ribosomal protein S14 (GI:183232711), a Ras family GTPase (EhRap2; GI: 183234340),
the 60S ribosomal protein L10 (GI:183234305), and a serine-rich E. histolytica protein
(SREHP; GI: 158992).
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Table 1. Isolation of cDNAs from E. histolytica over-expressors without (Control) and with
(Selected) selection with 2 mM wortmannin.
GeneInfo
Identifier
number (GI)
183233207
25989677
183232711
183234340
183234305
183233949
183232055
158992
67479580
67481134
183232640
25989681
183230706
183234759
67473330
1070154
183234628
183233565
67466875
183231333
183233272
183233845
183233758
183231176
183235741
183230765
732691
183232219
183230617
183230481
183230950
183230551
183236693
183231806
183230634
183232892
67469498
183232074
Total

Gene Name
Actin Binding Protein, EhCoactosin
Ehapt2 retrotransposon
40S ribosomal protein S14, putative
Ras family GTPase, EhRap2
60S ribosomal protein L10, putative
60S ribosomal protein L7, putative
60S ribosomal protein L17, putative
SREHP
Alcohol dehydrogenase, putative
40S ribosomal protein S25, putative
Hypothetical protein, H644
Ehapt2 retrotransposon
40S ribosomal protein S12, putative
40S ribosomal protein S7, putative
60S ribosomal protein L7a, putative
Profilin
60S ribosomal protein L7, putative
Hypothetical protein, BAR- and SH3-domains containing protein
40S ribosomal protein S25, putative
60s ribosomal protein L4, putative
Serine protease inhibitor, putative
60S ribosomal protein L14, putative
60S ribosomal protein L13, putative
Enolase, putative
60S ribosomal protein L15, putative
60S ribosomal protein L9
Alcohol dehydrogenase 3
Hypothetical protein
60S ribosomal protein L23, putative
40S ribosomal protein S9, putative
C2 domain containing protein
Vacuolar ATP synthase subunit E, putative
Serine-rich protein
60S ribosomal protein L11, putative
Hypothetical protein, mRNA
40S ribosomal protein S7, putative
Rho GTPase activating protein, putative
Hypothetical protein

Number of
Isolates
(Control)
2
1
4
1
1
5
3
1
7
4
6
2
0
0
0
0
0
0
1
1
2
2
4
4
5
6
6
9
1
1
3
1
1
1
1
1
1
1
89

Number of
Isolates
(Selected)
13
12
9
8
7
7
5
4
3
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
90

Table 3.1. Isolation of cDNAs from E. histolytica over-expressors without (Control) and
with (Selected) selection with 2 mM wortmannin.
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The cDNA encoding EhCoactosin was the most highly enriched of the cDNAs and
was present in 14.4% of the bacterial clones that had been transformed with episomes
isolated from trophozoite survivors. The corresponding protein is predicted to be 148
amino acid long (16.2 kDa) and was identified in a proteomic analysis of purified
phagosomes from E. histolytica (38). Like other coactosins, EhCoactosin belongs to the
ADF-H domain family of proteins and contains a putative F-actin binding domain. It is
also predicted to possess putative a N- glycosylation, a myristoylation, several casein II
kinase and a protein kinase C phosphorylation sites (Fig. 3.2A). Although domain search
yielded N-glycosylation site, it is not known whether EhCoactosin is a cytoplasmic or
plasma membrane protein. Presence of numerous phosphorylation sites on EhCoactosin
indicates a possible role for this protein in cell signaling in E. histolytica. A sequence
alignment revealed that EhCoactosin shares high homology with coactosins from other
systems (Fig. 3.2B). Importantly, Lys75 of human coactosin, which is required for
interaction with F-actin, is conserved in EhCoactosin, suggesting that the E. histolytica
protein is an authentic actin-binding protein. The 129LKKAGG134 sequence motif, and
specifically, Lys131, on the C-terminal end of human coactosin is necessary for
interaction with 5-lipoxygenase (5-LO), an enzyme that is involved in leukotriene
biosynthesis (39). Although, E. histolytica does not appear to possess 5-LO-like proteins,
EhCoactosin harbors a similar motif at its C-terminus, which may facilitate its interaction
with other proteins.
The cDNA encoding the serine-rich E. histolytica protein (SREHP) was present in
4.4% of the bacterial clones that had been transfected with the episomes isolated from
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trophozoites survivors. This protein is so named because it possesses a high serine
content. It is proposed to be a cell surface receptor that may facilitate host-parasite or
parasite-parasite interaction through chemoattraction (40). Its potential as a vaccine target
has also been established (41). Since SREHP is a cell surface protein, a potential
chemoattractant, and is, itself, phosphorylated, it may also possess signaling function.
Thus, it was intriguing to isolate it in a screen for protein partners of PI3K signaling.

Figure 3.2. Schematic of domains found in EhCoactosin and sequence comparison of
coactosin from E. histolytica with those of other species. (A) EhCoactosin is a F-actin
binding protein with a postulated molecular weight of 16.2 kDa (148 amino acids). It is
predicted to have an actin depolymerization factor homology (ADF-H) domain (orange
hexagon), a N-glycosylation site (blue vertical line), a N-myristoylation site (gray vertical
line), 4 casein kinase II phosphorylation sites (red flags labeled C), and a protein kinase C
phosphorylation site (red flag labeled P). (B) The predicted amino acid sequence of
EhCoactosin was aligned with coactosin from other organisms using ClustalW multiple
sequence alignment v1.4 (MacVector v9.0).Conserved amino acids are shaded and the
consensus sequence is indicated below the aligned sequence. The E. histolytica ADF-H
domain is indicated by the red line. Asterisks represent the lysine residues, Lys75 and
Lys131, of human coactosin, that are essential for binding to F-actin and 5-lipoxygenase,
respectively.
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The cDNA encoding EhRap2 was isolated from 8.9% of bacterial clones that had
been transfected with episomes from trophozoites survivors. EhRap2 is a member of Rap
family GTPases. Rap GTPases are known to participate in PI3K signaling in other
systems (26, 42), supporting the validity of our screen. Because of its known connection
to PI3K signaling, we did not consider EhRap2 for further studies. The cDNA encoding
the 40s ribosomal protein S14, the 60s ribosomal protein L10 and the ehapt2
retrotransposable element were isolated from 10%, 7.8% and 13.3% of bacterial clones
that had been transfected with episomes from trophozoites survivors, respectively. These
genes were also not chosen for further study because over- expression of ribosomal
proteins or retrotransposons may have profound non-specific effects on protein synthesis
and gene expression. Furthermore, cDNAs encoding ribosomal proteins were also
identified in the unselected control population (Table. 1). EhCoactosin was selected for
additional analysis because it was the most abundant cDNA isolated in the screen.
SREHP was also selected because of its potential as a signaling molecule and its
importance as a vaccine target.
Authentication of EhCoactosin and SREHP. Expression vectors encoding EhCoactosin
and SREHP, isolated from the original screen, were retransfected into wild-type
trophozoites to construct 2nd generation cell populations over-expressing these proteins.
Over-expression of SREHP and EhCoactosin transcripts was confirmed by qPCR (Fig.
3A and B). SREHP or EhCoactosin transcripts exhibited 3.3- and 7.1-fold higher
abundance, respectively, in the 2nd generation transgenic cell lines than in the parental
controls (Fig. 3.3 A and B).
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Figure 3.3. qPCR confirms over-expression of EhCoactosin and SREHP. RNA from
untransfected (wildtype; WT) log phase E. histolytica trophozoites or from trophozoites
transfected with an expression vector encoding EhCoactosin or SREHP was used for
qPCR analysis of expression. The ssRNA gene was used a loading control. The data
represent the mean ±S.D of ≥2 trials. (A) SREHP was expressed at approximately 3.6
(±0.5)-fold over wildtype (WT) cells. (B) EhCoactosin was expressed at approximately
7.1 (±1.8)-fold over wildtype (WT) levels.

To validate the identification of EhCoactosin and SREHP in our screen, we
exposed the 2nd generation transgenic cell lines to selection with 1 mM and 2 mM
wortmannin for 3 days and re-assessed toxicity. These cell lines exhibited significantly
higher survival after exposure to wortmannin as compared to control cells (Fig. 3.4). To
test if the decreased susceptibility to the drug was due simply to the presence of the
episomal DNA fragment, we exposed another cell line over-expressing an irrelevant
protein, EhLIMA, from the same expression vector (24). There was no significant
increase in the number of survivors after wortmannin treatment in the EhLIMA-
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expressing population (Fig. 3.4). This suggests the isolation of SREHP and EhCoactosin
via the original screen was authentic.

Figure 3.4. SREHP- and EhCoactosin-over-expressors are less susceptible to wortmannin
toxicity. Transgenic trophozoites were exposed to 1 mM or 2 mM wortmannin for 3 days,
after which viability was assessed. The data are reported as a percent of untreated control
amoebae and represent the mean ±S.D of 3 trials (**P<0.01). SREHP- and EhCoactosinover-expressing cells exhibited increased survival in the presence of wortmannin when
compared to untransfected wild-type (WT) cells or another transgenic cell line overexpressing an irrelevant gene, EhLIMA, from the same expression vector.

EhCoactosin or SREHP could represent false positives if their over-expression in E.
histolytica leads to a non-specific multi-drug resistant phenotype. To address this
possibility, we examined the specificity of the response to wortmannin by testing the
susceptibility of EhCoactosin- and SREHP-expressing cells to an unrelated small
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molecule, cycloheximide, as previously described (24). There was no significant
difference in the percentage of surviving cells between the 2nd generation transgenic cell
lines and control cells after exposure to cycloheximide (Fig. 3.5). This indicated that the
isolation of EhCoactosin and SREHP from our original screen was not due to a multidrug resistance phenotype characterized by non-specific extrusion of small molecules.

Figure 3.5. Cycloheximide is toxic to E. histolytica cells over-expressing SREHP and
EhCoactosin. Transgenic trophozoites were exposed to 100 nM cycloheximide for 48 h
andviability was assessed. The data are presented as a percent of untreated control cells
and represent the mean ±S.D of 3 trials. Cycloheximide was toxic to both wild-type (WT)
and transgenic amoebae. Therefore, cells over-expressing SREHP and EhCoactosin do
not exhibit a multidrug resistance phenotyope.
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Although SREHP has been characterized (40, 41, 43, 44), little is known about
EhCoactosin except that it is associated with E. histolytica phagosomes (38). In other
systems, increased expression of coactosin correlates with increased cell motility (45,
46). Therefore, to verify EhCoactosin as an authentic coactosin-member family, we
performed a previously published under-agar motility assay (47) on the 2nd generation
EhCoactosin over-expressors. EhCoactosin-expressing cells displayed increased motility
as compared to untransfected control trophozoites (Fig. 3.6) suggesting that this protein,
like other coactosins, has a cell migration function in E. histolytica.

Figure 3.6. Cell over-expressing EhCoactosin display increased cell motility. A motility
assay was performed on EhCoactosin over-expressors or untrasfected wild-type (WT)
cells. Images of cells moving under agar were captured using confocal microscopy. The
distance migrated by the trophozoites was measured. The data represent the mean ±S.D
of 3 trials (***P<0.001).
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Alterations in PI3K signaling affects expression of EhCoactosin and SREHP. We used an
independent genetic test to affirm the connections between EhCoactosin or SREHP with
PI3K. Previously, it was reported that a transgenic cell line over-expressing a GFP-tagged
pleckstrin homology (PH) domain, from mammalian Bruton’s tyrosine kinase (GFPPHBtk), exhibited reduced phagocytosis (10), increased motility (10), and decreased levels
of PI(4,5)P2 (48). Since the levels of PI(4,5)P2 and PI(3,4,5)P3 are tightly coordinated, we
predicted that PI(3,4,5)P3 abundance might also be altered in this cell line. Thus, we
measured the levels of PI(3,4,5)P3 using a lipid dot blot analyses of the whole cell
extracts of the GFP-PHBtk cell line. Compared to control wildtype trophozoites, GFPPHBtk-expressing cells exhibited approximately 50% increase in PI(3,4,5)P3 levels (Fig.
3.7 A&B). Given that PI(3,4,5)P3 is the product of PI3K, increased levels of this lipid
may be the genetic equivalent to enhanced PI3K activity.
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Figure 3.7. GFP-PHBtk over-expressors display altered PI(3,4,5)P3 levels.
Phosphoinositides were extracted from whole-cell lysates, and PI(3,4,5)P3 levels were
measured using dot blots with antibodies specific to PI(3,4,5)P3. Blot densities were
analyzed by Image J software and reported as arbitrary densitometric units. PI(3,4,5)P3
levels were higher in GFP-PHBtk-expressing cells than in wild-type (WT) cells. The data
represent the mean ±S.D of 2 trials.

Products of PI3K may propagate a signal by interacting with and phosphorylating
downstream effector proteins (reviewed in (7)). One outcome of signaling is changes in
gene expression levels (49-51). Therefore, we determined the impact of altered levels of
PI(4,5)P2 and PI(3,4,5)P3, in the GFP-PHBtk-expressors, on EhCoactosin and SREHP
transcript levels. There was a 1.5-fold increase in the abundance of SREHP transcripts
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(Fig. 3.8 A) and a 3.4-fold increase in the abundance of EhCoactosin transcripts (Fig. 3.8
B) in cells expressing GFP-PHBtk. One possibility is that signaling via E. histolytica PI3K
leads to increased expression of these two genes. Thus, an overabundance of EhCoactosin
or SREHP may have allowed the cells to overcome the PI3K-inhibitory effects of
wortmannin. Overall, the expression data support the connection between PI3K signaling
and EhCoactosin and SREHP.

Figure 3.8. GFP-PHBtk over-expressors possess increased levels of EhCoactosin and
SREHP transcripts. RNA from untransfected (wildtype; WT) log phase E. histolytica
trophozoites or from trophozoites expressing GFP-PHBtk was used for qPCR analysis of
SREHP and EhCoactosin expression. The ssRNA gene was used a loading control. The
data represent the mean ±S.D of 2 trials. (A) SREHP was expressed at approximately
1.65 (±0.07)-fold over WT cells while (B) EhCoactosin was expressed at approximately
3.4 (±0.57)-fold over WT levels. Thus, GFP-PHBtk cell line possesses higher levels of
transcript for EhCoactosin and SREHP.

104

DISCUSSION
In this study we utilized a functional genomics approach to identify genes that may
directly or indirectly function in the PI3K pathway in E. histolytica. We uncovered at
least one gene, a Rap GTPase, that has been shown to participate in PI3K signaling in
other systems. Our study also identified several genes not previously identified as
partners in PI3K signaling including SREHP and EhCoactosin. We utilized an
independent genetic test to support the roles of SREHP and EhCoactosin in the PI3K
pathway. The assignment of SREHP and EhCoactosin as putative partners in PI3K
signaling is novel.
Coactosin, an F-actin binding protein, was first isolated from the actin-myosin
complex of Dictyostelium discoideum (45). Subsequently, coactosin-like proteins (CLPs)
have been identified in other systems (46, 52, 53). Coactosin contains an actin
depolymerizing factor homology (ADF-H) domain, a structurally conserved motif that
allows proteins to interact with G- and/or F-actin, and to remodel the actin cytoskeleton
(reviewed in (54)). Both in vitro and in vivo, coactosin only binds F-actin (46, 52, 55).
Unlike other ADF-H domain-containing proteins, coactosin does not promote actin
filament elongation or disassembly. However, D. discoideum coactosin has been shown
to weakly interfere with barbed-end capping of actin filaments (55). Therefore, it has
been suggested that, in vivo, coactosin regulates actin dynamics in a complex with other
proteins (56). EhCoactosin possesses an ADF-H domain; however, it remains to be seen
if it binds F-actin and if it has additional interacting protein partners.
Importantly, coactosin has been implicated in cell motility. In D. discoideum,
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coactosin is concentrated in pseudopods (45). In developing chick embryos, coactosin is
expressed in migrating neural crest cells (46). Additionally, the levels of coactosin
mRNA are higher in motile and migrating cells. For example, in D. discoideum, mRNA
levels of coactosin reach a peak in aggregating cells that respond chemotactically to
cAMP (45). There is also evidence for local translation of coactosin mRNAs at cellular
extensions in oculomotor nerve (46) and in the pseudopods of human metastatic tumor
cells (57). Our finding that the level of EhCoactosin transcript is higher in the GFPPHBtk-over-expressors (this study) that also exhibit increased motility (10) and that overexpression of EhCoactosin is sufficient to increase motility (this study) suggest that
EhCoactosin is an authentic member of the coactosin family.
Coactosin may also play a role in phagocytosis in lower eukaryotes as evidenced by
its identification in protein analyses of isolated phagosomes of D. discoideum (58, 59)
and E. histolytica (38). PI3K, itself, also localizes to E. histolytica phagosomes (38). The
mechanism by which increased levels of PI(3,4,5)P3 leads to increased expression of
EhCoactosin has not been discerned. However, given that both proteins localize to the
same organelle, and given that EhCoactosin has several phosphorylation sites, it is also
possible that, in addition to regulating expression of EhCoactosin, PI3K may also
regulate activity of EhCoactosin by phosphorylation. It remains to be seen if PI3K or the
products of PI3K and EhCoactosin physically interact.
SREHP has also been implicated in E. histolytica phagocytosis. In particular,
trophozoites can induce host cell apoptosis via caspase-3 activation (60). This is followed
by preferential phagocytosis of apoptotic cells over healthy cells (60). SREHP is thought
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to be a cell surface receptor facilitating the binding and uptake of apoptotic host cells
(44). SREHP also undergoes posttranslational modifications including, phosphorylation,
O-linked terminal N- acetylation, and acylation (40). Given its subcellular localization,
posttranslational modifications and function as a receptor for apoptotic cells, it has been
hypothesized to be involved in cell signaling (44). In the current study, identification of
SREHP supports its role in signal transduction perhaps through a PI3K-mediated
pathway.
We also identified genes that participate in PI3K signaling in other systems. These
were not further examined in the current study. Although not highly enriched, the cDNAencoding profilin was identified in the screen. Profilin is an actin-binding protein that
stimulates PI3K activity in a concentration-dependent fashion (28). There is also
evidence for direct association of profilin with PI3K (28). EhRap2, a member of Ras
superfamily of small GTP-binding proteins, was highly enriched in the wortmanninselected population. E. histolytica possesses two Rap isoforms, EhRap1 and EhRap2, that
share over 91% identity with each other (61). EhRap2 shares at least 60% identity with
Rap1 proteins from other systems and at least 50% identity with Rap2 proteins from other
systems. Like other Rap1 proteins (42, 62), EhRap2 localizes to phagosomes (9). In
platelets, PI3K can activate Rap1 (27). In D. discoideum, Rap1 interacts with the Ras
binding domain of PI3K to bring about modulation of cell polarity and pseudopod
formation (26). EhRap2 possesses all of the effector binding domains, and switch I and
switch II regions (data not shown) that are necessary for interaction with PI3K (reviewed
in (63, 64)). Since, in E. histolytica, EhRap2 (65), PI3K (38) and the products of PI3K (8-
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10) localize to phagosomes, and since EhRap2 was highly enriched among the
wortmannin-selected population (this study), it is reasonable to hypothesize that similar
local EhRap2/PI3K associations exist.
In our study, the cDNA encoding ehapt2 was also highly enriched in the
wortmannin- selected population. The genome of E. histolytica contains non-longterminal-repeat (non-LTR) retrotransposons (66, 67). These include the long interspersed
repetitive elements (LINEs), and the short interspersed repetitive elements (SINEs).
Ehapt2 is a member of the EhSINE1 family of retrotransposable elements. Ehapt2 is
present in the vicinity of protein-coding genes (68), and may influence the expression of
such genes (22). For example, ehapt2 is present in high copy number in virulent
Entamoeba species (15, 68). Incidentally, the Heat shock protein (Hsp) 70 family,
GTPases of the AIG1 family, and the large leucine-rich repeats BspA-like surface protein
family that are physically linked to transposable elements display higher expression
levels in virulent strains of E. histolytica (22). Although Yadav et al. (69), reported that
laboratory strains of E. histolytica may be retrotransposition-incompatible, it is possible
that over-expression of ehapt2 (current study) resulted in transposition of this element
upstream of genes that play a role in PI3K pathway and in changes in gene expression. If
so, the identification of ehapt2 retrotransposon in the screen would have been a false
positive. Discerning the genomic position of ehapt2 in trophozoites that are less sensitive
to wortmannin is necessary to fully understand the connection, if any, to PI3K signaling.
Hypothetical proteins were also isolated in our screen. One such protein, H644
(GI:183232640), that was present in the wortmannin-selected survivors, was previously
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identified in a screen for negative regulators of phagocytosis (24). Over-expression of
H644 strongly reduced phagocytosis of human red blood cells by E. histolytica (24).
Moreover, H644 possesses a significant number of putative phosphorylation sites
suggesting a role in signal transduction. The second hypothetical protein that was
identified in our screen (GI:183233565), contains a N-terminal Bin-Amphiphysin-Rvs
(BAR) superfamily domain and a C-terminal SH3 domain. BAR domain proteins are
evolutionarily conserved and can bind to the plasma membrane. Specifically, BAR
domains induce, stabilize or detect membrane curvatures and facilitate the interaction
between the plasma membrane and the underlying cytoskeleton (70). Many BAR
domain-containing proteins also possess SH3 domains that can participate in signal
transduction and mediate actin cytoskeletal rearrangement (71). For example, in
mammalian cells, Endophilin B1, that carries both the BAR and SH3 domains, activates
PI3K and induces autophagy (72). Thus, the identification of these hypothetical genes in
our screen may not be fortuitous.
Ribosomal proteins were highly enriched in our screen. These may or may not be
authentic participants in PI3K signaling. In a screen of yeast deletion mutants for
wortmannin sensitivity, 119 of the 1067 genes were functionally characterized to be
involved in protein synthesis, including several ribosomal proteins (25). Therefore, it is
possible that in our study, over-expression of ribosomal proteins may have a direct or
indirect connection to PI3K-based signaling.
It is logical to predict that over-expression of PI3K, itself, would protect the cells
from near-lethal doses of a PI3K inhibitor. However, we did not identify cDNAs
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encoding PI3Ks in our screen. Our screen was not exhaustive. For instance, the episomes
carrying cDNA from wortmannin-selected trophozoites population were transformed into
E. coli. However, cDNAs from only 96 transformants were sequenced. Therefore, it is
possible that additional sequencing may identify cDNAs encoding E. histolytica PI3Ks.
In addition, we may have utilized a very high wortmannin selection pressure, which
could have been lethal for even the PI3K-over-expressing cells. The E. histolytica
genome possesses at least 8 putative PI3Ks (data not shown), but it remains to be seen
which of these are authentic PI3Ks.
This study enhances our knowledge of PI3K signaling in E. histolytica, which, in
turn, provides insight into virulence. This study also illustrates the utility of full genome
functional genetic screens in this parasite. Our screen was based on a simple phenotype,
cell viability. Predictably, future forward and reverse genetic screens, based on more
complex phenotypes, are likely to lead to the functional annotation of many genes in this
organism. This will, undoubtedly, reveal new targets for the development of vaccines or
therapies against E. histolytica infection.
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CHAPTER 4
SUMMARY OF MAJOR RESEARCH FINDINGS

The protozoan parasite, Entamoeba histolytica, causes amebic dysentery and
amebic liver abscess (ALA). Upon entering the human host, cellular processes such as
adhesion, phagocytosis, motility and secretion play a vital role in its propagation and
pathogenicity. In other systems, each of these cellular processes is preceded by activation
of signal transduction pathways, which often involve membrane phosphoinositides such
as phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) and phosphatidylinositol 3,4,5trisphosphate (PI(3,4,5)P3). In mammalian cells PI(4,5)P2 is maintained in steady-state
levels and is enriched in lipid rafts, cholesterol-rich membrane microdomains. Hydrolysis
of PI(4,5)P2 yields secondary messengers such as inositol trisphosphate (IP3) and diacyl
glycerol (DAG). Conversely, PI(3,4,5)P3 is generated transiently and rapidly by PI3kinase (PI3K) in response to stimulation. The aim of this research was- 1) to determine
the role of cholesterol in regulating localization of PI(4,5)P2 in E. histolytica, 2) to
identify the genes that are involved in PI3K signaling in this parasite by a chemical
genomics screen of E. histolytica overexpression library.

BIOLOGICAL RELEVANCE OF EXPOSURE OF TROPHOZOITES TO
CHOLESTEROL TO STUDY THE LOCALIZATION OF PI(4,5)P2
Cholesterol is a major constituent of eukaryotic plasma membrane, and is known to
enhance virulence functions in E. histolytica (Reviewed in (1)). For instance, it is
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possible to revive virulence of avirulent E. histolytica strains by supplying medium
withcholesterol (2, 3) or via repeated passage through liver, which is a major site of
cholesterol synthesis (4, 5). In addition, E. histolytica possesses lipid rafts, which are
cholesterol- and sphingolipid-rich membrane domains (6). In mammalian cells, lipid rafts
are known to organize signaling molecules including PI(4,5)P2 (7, 8). The lipid raft
disrupting agent, MβCD, causes delocalization of PI(4,5)P2 from cholesterol-rich
fractions in mammalian cells leading to a loss of hormone-stimulated turnover of
phosphoinositides (7, 9).
In our study, we utilized various concentrations of cholesterol that reflected the
differences in cholesterol concentrations that E. histolytica cells are exposed to in their
human hosts. For instance, serum cholesterol level in a normal, healthy individual is
around 2 mg/ml, while individuals with over or below 2 mg/ml are hypercholesteromic
and hypocholesteromic, respectively (10). Additionally, the parasites also encounter
different extracellular cholesterol levels depending on their location in the human host
(e.g., liver versus intestine). A strong correlation between cholesterol and virulence
comes from an early in vivo study that demonstrated that hypercholesteromia enhances
intestinal lesions and ALA formation in an animal model of infection (11). Therefore,
given the importance of cholesterol in maintaining membrane structure and assembling
signaling molecules, and its role in mediating virulence in E. histolytica, we utilized
cholesterol to study the submembrane and subcellular localization of PI(4,5)P2 and its
impact on cellular function, namely motility.
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SUBCELLULAR AND SUBMEMBRANE LOCALIZATION OF PI(4,5)P2 IN E.
HISTOLYTICA
In mammalian cells there is evidence for existence of different cellular pools of
PI(4,5)P2 which explains the complex roles of PI(4,5)P2 (reviewed in (12)). In E.
histolytica, we observed compartmentalization of PI(4,5)P2 in lipid rafts as well as in the
actin-rich pellet fraction at steady-state. We also showed that exposure to cholesterol
resulted in enrichment of PI(4,5)P2 in detergent-resistant membrane (DRM), and
specifically, in lipid rafts, without an increase in total cellular level of PI(4,5)P2. We
utilized a recombinant GST-PHPLCD1 probe to determine the subcellular localization of
PI(4,5)P2. We found that PI(4,5)P2 uniformly decorates the plasma membrane of this
parasite. Using the uroid marker, concanavalin A (ConA), we also showed that in
polarized cells, both lipid rafts and its constituent signaling lipid, PI(4,5)P2, localize to
the uroids. Additionally, MβCD depletes the DRM and plasma membrane of PI(4,5)P2
suggesting a requirement of cholesterol-richness for proper localization of PI(4,5)P2 to
the plasma membrane.
Our observation that lipid rafts and uroids become enriched with PI(4,5)P2 upon
exposure to cholesterol may be attributed to the following two mechanisms:- 1)
Translocation of PI(4,5)P2 between membrane compartments in a cholesterol- dependent
manner. Simple translocation of PI(4,5)P2 between membrane domains would represent a
rapid way to regulate lipid signaling throughout infection. In mammalian cells, there is
evidence that lipid rafts can deliver signaling molecules to uroids during cell migration
and polarization (13-16). Therefore, it is possible that a similar lipid-raft mediated
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delivery of PI(4,5)P2 to uroids occurs in E. histolytica.
2) Rapid hydrolysis and synthesis of PI(4,5)P2 in rafts, which would maintain an apparent
constant total cellular level of this lipid. Local synthesis of PI(4,5)P2 at uroids could also
explain the enrichment that we observed in the trailing edge upon exposure to cholesterol.
A number of reports in other systems have shown that key PI(4,5)P2 synthesizing
enzymes also localize to uroids (17-20). However, whether these enzymes localize to
uroids of E. histolytica remains to be determined.
This study represents the first analysis of the submembrane and subcellular
localization of PI(4,5)P2 in E. histolytica. Since PI(4,5)P2 can bind actin-binding proteins
and modulate the actin cytoskeleton, and since such proteins have been identified in the
uroids of E. histolytica (21), this study opens up the possibility that in this parasite,
PI(4,5)P2 may serve as a bridge at the uroid, connecting the cytoskeleton to plasma
membrane through various actin-binding proteins. In the future it will be necessary to
determine if interactions between PI(4,5)P2 and actin cytoskeleton-modifying proteins at
the uroids are necessary for polarization and migration of E. histolytica trophozoites. To
identify PI(4,5)P2-interacting protein partners in the uroid, we could utilize commercially
available PI(4,5)P2-coated beads (Echelon Bioscience, Utah), and perform protein pulldown experiments of isolated E. histolytica uroids. Furthermore, generation of E.
histolytica cells with reduced levels of the enzymes that are responsible for PI(4,5)P2
synthesis (e.g., knockdowns of PIP5K), would enable us to determine if there is an
association between PI(4,5)P2 and cell polarization and migration morphologies.
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EXPOSURE TO CHOLESTEROL INCREASES MOTILITY, INTRACELLULAR
CALCIUM LEVELS, ADHESION AND ACTIN POLYMERIZATION
In other systems, PI(4,5)P2 plays an essential role in cell motility. In cholesteroltreated trophozoites, PI(4,5)P2 became asymmetrically distributed. Since asymmetry is a
hallmark of motile cells, we hypothesized that exposure to cholesterol was enhancing
motility. Indeed, upon exposure to cholesterol, not only did cells traverse longer
distances, but there was also an apparent increase in the number of motile cells. This
suggested a possible role for cholesterol in mediating motility in E. histolytica.
We also found that treatment with cholesterol resulted in a significant dosedependent increase in the downstream effector of PI(4,5)P2, Ca2+, and a significant
increase in actin polymerization (Fig. A-1) and adhesion (Fig. B-1). It is reasonable to
hypothesize that an increase in adhesion would reduce motility. Thus, our observation is
paradoxical. Speed is determined by the ratio of contractile force to adhesiveness (22).
One explanation for the data is that the effect of cholesterol on contractile force is
stronger than the effect of cholesterol on adhesion. In support of this, the effect of
cholesterol on adhesion was saturable whereas the ability of cholesterol to increase the
level of intracellular Ca2+ was dose-dependent (at least for the concentrations of
cholesterol used in this study). Ca2+ is a potent stimulator of motility through activation of
MLCK leading to an increase in myosin II-based contractility. This potency was seen in
the current study as an increase in intracellular Ca2+ was accompanied by a robust
augmentation of motility after exposure to cholesterol. A summary of the research
findings is presented in Fig 4.1.
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Importantly, our observation that an increase in PI(4,5)P2 in rafts and uroids is
accompanied by increases in intracellular Ca2+ and motility is suggestive of raft-mediated
signaling from PI(4,5)P2. However, it remains to be seen if the effect of PI(4,5)P2 on
motility, after exposure to cholesterol, is direct or indirect. One way to test this would be
to reduce the levels of PI(4,5)P2 in cells by knockdown of PI(4,5)P2-synthesizing
enzymes and determine if exposure to cholesterol alone is sufficient to upregulate
motility.

Figure 4.1. Effect of cholesterol on E. histolytica trophozoites. At steady- state, PI(4,5)P2
is localized to the lipid rafts and actin-rich fractions of the E. histolytica detergentresistant membrane (DRM).	
   The trailing edge of polarized trophozoites, uroids, are
highly enriched in lipid rafts and its constituent lipid, PI(4,5)P2. Exposure to cholesterol
results in enrichment of PI(4,5)P2 in DRM and specifically in the lipid raft fractions.
Polarization and enrichment of uroid and rafts with PI(4,5)P2 were enhanced upon
treatment of E. histolytica cells with cholesterol. Exposure to cholesterol also increased
intracellular Ca2+ which is a downstream effector of PI(4,5)P2, and a concomitant
increase in motility, adhesion, and F-actin polymerization.
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This research is important for several reasons. First, this study is the first to
demonstrate that an important function regulating invasion, i.e, motility, is influenced by
extracellular cholesterol. This significantly advances our understanding of pathogenicity.
Second, this study was the first to determine the localization of PI(4,5)P2 to lipid rafts in
E. histolytica. Thus, raft-mediated PI(4,5)P2-signaling, like in mammalian cells, is
possible in this pathogen. Third, to our knowledge this is the first study to demonstrate
the localization of PI(4,5)P2 to uroids in eukaryotic cells and therefore, could be extended
to other systems. In the future, it will be necessary to identify mechanism of PI(4,5)P2enrichment in rafts and uroids upon exposure to cholesterol. Overall, an understanding of
how cholesterol impacts the submembrane and subcellular localization of PI(4,5)P2 in E.
histolytica could be key to unraveling the molecular mechanism by which cholesterol
regulates virulence.

FORWARD GENETICS APPROACH TO STUDY PI3K PATHWAY IN E.
HISTOLYTICA
Genome-wide over-expression is a forward genetic approach adopted to identify
and select for a particular phenotype in a population of cells over-expressing all or a
subset of genes form the genome. For our second study, we utilized a functional
genomics screen to identify genes that may operate in the PI3K pathway in E. histolytica.
We treated a population of trophozoites, which were transfected with E. histolytica overexpression cDNA library, with a near-lethal dose of the PI3K inhibitor, wortmannin. This
screen was based on the rationale that survivors may be over-expressing gene products
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that directly or indirectly function in the PI3K pathway in E. histolytica. We then
identified the over-expressed genes in survivors.
We isolated a cDNA encoding a Rap GTPases that was previously shown to
participate in the PI3K pathway. This supports the validity of our approach. Genes
encoding a coactosin-like protein, EhCoactosin, and a serine-rich E. histolytica protein
(SREHP) were also identified in our screen. The assignment of these proteins as putative
partners in PI3K signaling is novel. While coactosin has been implicated in cell motility
(23), SREHP is thought to be a cell surface receptor facilitating the binding and uptake of
apoptotic host cells (24). To our knowledge, this is the first forward genetics screen
adapted to reveal genes participating in PI3K pathway in this pathogen.

GFP-PHBTK as a Tool to Study PI3K Signaling Pathway
A transgenic cell line over-expressing a GFP-tagged pleckstrin homology (PH)
domain, from mammalian Bruton’s tyrosine kinase (GFP-PHBtk) was used to further
affirm the connections between EhCoactosin or SREHP with PI3K. PHBtk is known to
specifically bind PI(3,4,5)P3. GFP-PHBtk-over-expressors have altered PI3K signaling
with decreased levels of PI(4,5)P2 (25), increased levels of PI(3,4,5)P3, that translates into
altered phenotype including, reduced phagocytosis, and increased motility (26). Given
that PI(3,4,5)P3is the product of PI3K, we believe that increased levels of this lipid may
be the genetic equivalent to enhanced PI3K activity. One outcome of PI3K-mediated
signaling is changes in gene expression levels (27-29). Therefore, we determined the
impact of altered levels of PI(4,5)P2 and PI(3,4,5)P3, in the GFP-PHBtk-expressors, on
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EhCoactosin and SREHP transcript levels. We found an increased abundance of
EhCoactosin and SREHP transcripts in cells expressing GFP-PHBtk. One possibility is
that signaling via E. histolytica PI3K leads to increased expression of these two genes.
Thus, we hypothesized that an overabundance of EhCoactosin or SREHP may have
allowed the cells to overcome the PI3K-inhibitory effects of wortmannin.
In the future, we plan to study the effects of PI(3,4,5)P3 on gene expression levels in
E. histolytica. To achieve this we plan to use the commercially available PI(3,4,5)P3loading kit (Echelon Biosciences, Utah), to supply wildtype E. histolytica cells with
additional PI(3,4,5)P3, and measure the changes in transcript abundance of EhCoactosin
and SREHP, if any. A potential pitfall of this technique is that, since PI(3,4,5)P3 regulates
a variety of cellular functions, this procedure could induce global changes in the cell that
may skew our results. Additionally, we also plan to determine the exact role of
EhCoactosin in the PI3K pathway. A recent study in chick development demonstrated
that coactosin is actively involved in actin polymerization, and plays a crucial role in
actin dynamism downstream of Rac1 signaling (30). In other systems, PI3K can activate
Rac1 (31), and E. histolytica contains a homologue of Rac1 that is essential for
cytokinesis and motility (32). Therefore, it is possible that overexpressors of Ehcoactosin,
which is downstream of PI3K-Rac1, is sufficient to overcome the possible defects in the
actin cytoskeleton induced by wortmannin. One way to test this hypothesis would be to
knockdown EhCoactosin. Given that decrease in actin dynamism is associated with cell
death (33), a knockdown of EhCoactosin could be fatal for the cells. Alternatively,
reduction of EhCoactosin may produce defective phenotype (such as inhibition of
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cytokinesis) associated with abnormal actin cytoskeleton.
Overall, this study enhances our knowledge of PI3K signaling in E. histolytica,
which, in turn, provides insight into virulence. This study also illustrates the utility of full
genome functional genetic screens in this parasite. Our screen was based on a simple
phenotype, cell viability. Predictably, future forward and reverse genetic screens, based
on more complex phenotypes, are likely to lead to the functional annotation of many
genes in this organism. This will, undoubtedly, reveal new targets for the development of
vaccines or therapies against E. histolytica infection.
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APPENDIX A
EFFECT OF CHOLESTEROL ON ACTIN POLYMERIZATION
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C to cholesterol enhances actin polymerization. F- and G-actin were
Figure A-1. Exposure
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EFFECT OF CHOLESTEROL ON E. HISTOLYTICA ADHESION
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Figure B-1. Exposure to cholesterol enhances trophozoite adhesion to uncoated 96-well
plates. E. histolytica trophozoites were serum starved and exposed to 0 to 3 mg/ml
concentration range of cholesterol. A standard adhesion assay was performed using 0
mg/ml (untreated control) cells and cholesterol-treated cells on 96-well plates. The data
are presented as a percentage of adhesion as compared to untreated control which was
arbitrarily set to 100%. Cholesterol treatment enhanced adhesion significantly in a dosedependent fashion up to 0.05 mg/ml cholesterol after which it remained unchanged (*,
P<0.5, **, P<0.01, ***, P<0.001). The data are the means + S.D. from >3 independent
experiments.
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